Department of Hematology

349  articles.  
* There may be some overlapped articles listed due to the difference of format.

  1. Michihide Tokuhira, Hitomi Nakayama, Kohtaro Toyama, Motoki Takano, Noriyoshi Iriyama, Atsushi Takahata, Eriko Sato, Yasutaka Senpuku, Maho Kawakami, Keigo Okada, Keisuke Tanaka, Takashi Abe, Yuki Osada, Koh Yamamoto, Junichi Watanabe, Toshiaki Hayashi, Yasunobu Sekiguchi, Yuta Kimura, Gaku Oshikawa, Masaru Nakagawa, Ken Suzuki, Takashi Kumagai, Shigeo Toyota, Katsuhiro Miura, Takayuki Ikezoe, Tomonori Nakazato, Takehiko Mori: Investigation of early mortality in the patients with newly diagnosed multiple myeloma: insights from a real-world cohort using J-CHAEGE-MM database. Int J Hematol. 2026.02; 123 (2): 233-246. ( PubMed , DOI )

  2. Hiromi Hayashi, Takeo Yamagiwa, Junya Kanda, Takayuki Ishikawa, Masashi Sawa, Yasuko Miyahara, Takayoshi Tachibana, Mitsumasa Watanabe, Yasunori Ueda, Yasuhiko Tsutsumi, Kazunori Imada, Shin-Ichiro Fujiwara, Tomomi Toubai, Kota Yoshifuji, Hirokazu Hirata, Hiroshi Kawabata, Masaaki Tsuji, Satoshi Wakita, Hiroki Yokoyama, Toshiyuki Kitano, Kazunori Murai, Yoshihisa Kataoka, Eri Kawata, Shun-Ichi Kimura, Ryusuke Yamamoto, Kotaro Miyao, Daisuke Nakayama, Akihiko Izumi, Takahito Kawata, Yoshiyuki Onda, Takashi Sakamoto, Chisaki Mizumoto, Toshio Kitawaki, Kouhei Yamashita, Atsushi Yonezawa, Tomoya Kawakami, Shunsaku Nakagawa, Risa Taniguchi, Tomohiro Terada, Akifumi Takaori-Kondo: Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia. Sci Rep. 2026.02; ( PubMed , DOI )

  3. Yu Yagi, Yusuke Kanemasa, Hideki Goto, Masahide Yamamoto, Kotaro Miyao, Maki Hagihara, Toshio Kitawaki, Tatsu Shimoyama, Ryo Hanajiri, Shinichi Makita, Go Yamamoto, Masatoshi Sakurai, Nobuharu Fujii, Takahide Ara, Yasuhiro Nakashima, Akiyo Yoshida, Hideyuki Nakazawa, Emiko Sakaida, Nobuhiro Kanemura, Haryoon Kim, Keisuke Kataoka, Yoshiko Atsuta, Koji Kato: Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy. Bone Marrow Transplant. 2026.02; ( PubMed , DOI )

  4. Mukae J, Akiyama H, Tanaka K, Yoshifuji K, Nogami A, Umezawa N, Umezawa Y, Yamamoto K, Nagao T, Yasuda S, Kanegane H, Takagi M, Mori T, Yamamoto M. : Classical Hodgkin lymphoma associated with immune deficiency and dysregulation exhibits a prognosis similar to sporadic cases but with distinct predictive markers. Ann Hematol. 2026.01; 105 (2): 48. ( PubMed , DOI )

  5. Tomotaka Suzuki, Tomoyasu Jo, Kota Yoshifuji, Tadakazu Kondo, Noriko Doki, Yoshinobu Kanda, Tetsuya Nishida, Yasushi Onishi, Noboru Asada, Takahiro Fukuda, Masashi Sawa, Yuta Hasegawa, Kentaro Serizawa, Shuichi Ota, Masatsugu Tanaka, Makoto Yoshimitsu, Yoshiko Atsuta, Junya Kanda: Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT. Br J Haematol. 2026.01; 208 (1): 219-228. ( PubMed , DOI )

  1. Keisuke Tanaka, Hiroaki Kikuchi, Yoshihiro Umezawa, Takehiko Mori, Kiyohide Fushimi, Masahide Yamamoto: Management of inpatient chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell malignancies: an analysis using the Japanese Diagnosis Procedure Combination database. Int J Hematol. 2025.12; 122 (6): 856-863. ( PubMed , DOI )

  2. Ran Zhao, Liang Zhang, Shuxin Dong, Kazuharu Kamachi, Saurabh Kumar Gupta, Hiroki Akiyama, Jalen Nguyen, G Lavender Hackman, Michael Andreeff, Alessia Lodi, Jo Ishizawa: Protocol for isolation of lipid droplets and mitochondria from acute myeloid leukemia cells for lipidomic analysis. STAR Protocol. 2025.12; 6 (4): 104257. ( PubMed , DOI )

  3. Yuma Noguchi, Takehiko Mori, Yasushi Onishi, Yukinori Nakamura, Minoru Kanaya, Shinichi Ito, Kosei Matsue, Shingo Yano, Makoto Onizuka, Tetsuya Nishida, Seitaro Terakura, Satoshi Yoshihara, Takeshi Maeda, Tatsuo Ichinohe, Yoshiko Atsuta, Katsuto Takenaka: Outcomes of allogeneic hematopoietic stem cell transplantation for acquired pure red cell aplasia. Int J Hematol. 2025.12; ( PubMed , DOI )

  4. Noriyoshi Iriyama, Hitomi Nakayama, Masaru Nakagawa, Atsushi Takahata, Eriko Sato, Motoki Takano, Keigo Okada, Kohtaro Toyama, Toshiaki Hayashi, Takashi Abe, Keisuke Tanaka, Yasuhiko Senpuku, Yuki Osada, Junichi Watanabe, Koh Yamamoto, Yasunobu Sekiguchi, Gaku Oshikawa, Yuta Kimura, Michihide Tokuhira, Ken Suzuki, Takashi Kumagai, Takayuki Ikezoe, Shigeo Toyota, Katsuhiro Miura, Tomonori Nakazato, Takehiko Mori: Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group. Int J Hematol. 2025.11; ( PubMed , DOI )

  5. Ayako Nogami, Towako Taguchi, Shomi Koyama, Katsutoshi Nagano, Kota Yoshifuji, Naoya Ichimura, Yutaka Nakajima, Takehiko Mori, Morito Kurata: Decoy cell detection and identification of adenovirus and BK polyomavirus in viral hemorrhagic cystitis by immunohistochemical evaluation of urine samples Japanese Journal of Transplantation and Cellular Therapy . 2025.10; 14 (4): 247-251.

  6. Kentaro Yamaguchi, Junji Koya, Kota Mizuno, Yosuke Mizukami, Kota Yoshifuji, Yuki Saito, Mariko Tabata, Sumito Shingaki, Mitsuhiro Yuasa, Yuta Ito, Kazutaka Nakashima, Kostiantyn Dreval, Ryan D Morin, Kenichi Chiba, Ai Okada, Yuichi Shiraishi, Koichi Murakami, Yasunori Kogure, Koichi Ohshima, Keisuke Kataoka: In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis. Blood Adv. 2025.10; 9 (19): 5040-5055. ( PubMed , DOI )

  7. Yasumasa Nakata, Takehiko Mori, Ayako Nogami: Paroxysmal Nocturnal Hemoglobinuria in Patients with Systemic Lupus Erythematosus: Diagnostic Challenges and Improvement with C5 Inhibitor Treatment Internal Medicine. 2025.10; ( DOI )

  8. Sakurai M, Kataoka K, Mizuno K, Mori T, Shirane S, Sakaguchi H, Mori T, Tanaka M, Tokunaga M, Onizuka M, Sakata-Yanagimoto M, Ishikawa J, Katayama Y, Ota S, Sawa M, Kato J, Hasegawa Y, Onodera K, Hattori N, Miyakoshi S, Takayama N, Nishida T, Kato K, Ishimaru F, Atsuta Y, Kanda J, Nakasone H, Terakura S: Risk Factors for and Impact of Pre-Engraftment Syndrome on Outcomes Following Single-Unit Cord Blood Transplantation in Adults. American journal of hematology. 2025.09; ( PubMed , DOI )

  9. Akihiko Izumi, Takayoshi Tachibana, Hiroto Ishii, Shin-Ichiro Fujiwara, Yuho Najima, Chikako Ohwada, Kota Yoshifuji, Yuto Hibino, Masatsugu Tanaka, Shinichi Kako, Shun-Ichi Kimura, Masaharu Tamaki, Shingo Yano, Hiroki Yokoyama, Daisuke Minakata, Shokichi Tsukamoto, Emiko Sakaida, Noriko Doki, Akira Yokota, Takuya Miyazaki, Nobuyuki Aotsuka, Yoshinobu Kanda: Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma. Hematol Oncol. 2025.09; 43 (5): e70136. ( PubMed , DOI )

  10. Koji Kato, Jun Kato, Hideki Goto, Takeshi Kobayashi, Yoshiyuki Takahashi, Emiko Sakaida, Hidefumi Hiramatsu, Masahide Yamamoto, Satoshi Yoshihara, Jun Ando, Katsuyoshi Koh, Kentaro Fukushima, Fumiko Iwamoto, Ranjan Tiwari, Nobuharu Fujii: Clinical outcomes of Japanese patients treated with out-of-specification tisagenlecleucel in a phase 3b trial. Cytotherapy. 2025.08; 27 (8): 938-943. ( PubMed , DOI )

  11. Hashimoto Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Kada A, Saito AM, Shimoda K, Sugimoto Y, Kurokawa T, Tomita A, Edahiro Y, Kiyoi H, Akashi K, Matsumura I, Takenaka K, Komatsu N: Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential Thrombocythemia. EJHaem. 2025.08; 6 (4): e70103. ( PubMed , DOI )

  12. Kanegane H, Miyamoto S, Kamiya T, Ohnishi H, Nishikomori R, Gennery AR, Mori T.: Allogeneic hematopoietic cell transplantation for autoinflammatory disorders. Int J Hematol. 2025.08; 122 (2): 190-198. ( PubMed , DOI )

  13. Yasumasa Nakata, Fumihiko Ouchi, Kota Yoshifuji, Daichi Sadato, Kouhei Yamamoto, Yuriko Kawase, Takehiko Mori: Comprehensive Genetic Analysis of Central Nervous System Involvement in Mycosis Fungoides: A Case Report. EJHaem. 2025.08; 6 (4): e70118. ( PubMed , DOI )

  14. Satoshi Yamasaki, Shohei Mizuno, Kota Yoshifuji, Eri Matsuki, Masashi Sawa, Takashi Akasaka, Naoyuki Uchida, Hitoji Uchiyama, Keisuke Kataoka, Nobuhiro Hiramoto, Yoshinobu Kanda, Kazuya Ishiwata, Toshio Wakayama, Takahiro Fukuda, Makoto Yoshimitsu, Makoto Onizuka, Marie Ohbiki, Yoshiko Atsuta, Ritsuro Suzuki, Shinichi Kako: Autologous stem cell transplantation from 2011 to 2022 in Japanese patients aged ≥ 65 years with relapsed or refractory diffuse large B-cell lymphoma. Ann Hematol. 2025.08; 104 (8): 4189-4199. ( PubMed , DOI )

  15. Atsushi Hamamura, Kazuya Sakai, Toshiki Mushino, Yasunori Ueda, Yoshiyuki Ogawa, Hiroyuki Noguchi, Akinao Okamoto, Hideo Yagi, Takehiko Mori, Masanori Matsumoto: Prognostic relevance of early clinical and laboratory findings in immune-mediated thrombotic thrombocytopenic purpura. Res Pract Thromb Haemost. 2025.07; 9 (5): 102974. ( PubMed , DOI )

  16. Kota Yoshifuji, Yotaro Motomura, Makiko Saito, Genji Kawade, Shiori Watabe, Kouhei Yamamoto, Mai Soejima, Ayako Nogami, Satoru Aoyama, Takehiko Mori, Toshikage Nagao: Tumor progression locus 2, a new potential prognostic factor and therapeutic target in activated B-cell-like diffuse large B-cell lymphoma. Blood Cancer J. 2025.05; 15 (1): 95. ( PubMed , DOI )

  17. Ikuyo Tsutsumi, Masahide Yamamoto, Takayuki Fujio, Nobuharu Kosugi, Gaku Oshikawa, Koh Yamamoto, Takasi Kumagai, Toru Miki, Daisuke Kudo, Shigeo Toyota, Yuichi Nakamura, Nobutaka Kawai, Masao Hagiwara, Takeshi Kobayashi, Ayako Arai, Takuya Komeno, Hiroshi Kojima, : A phase 2 trial of VRD induction for transplant-eligible Japanese patients with newly diagnosed multiple myeloma. Int J Hematol. 2025.05; ( PubMed , DOI )

  18. Akiyama H, Nishida Y, Chang KH, Bedoy AD, Muftuoglu M, Ma W, Basyal M, Hirschi Z, Honma D, Tsutsumi S, Wang J, Zhang W, Huang X, Rampal RK, Oluwole OO, Bixby DL, Daver NG, Andreeff M: Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia. Blood cancer journal. 2025.04; 15 (1): 76. ( PubMed , DOI )

  19. Nakamura N, Morishita T, Hayashi H, Okabe M, Nakasone H, Uchida N, Doki N, Fukuda T, Yoshihara S, Tanaka M, Nishida T, Hasegawa Y, Matsuoka KI, Sawa M, Eto T, Onizuka M, Katayama Y, Kato K, Ishimaru F, Tabuchi K, Atsuta Y, Kanemura N, Teshima T: The impact of the SARS-CoV-2 pandemic on umbilical cord blood transplantation in Japan: insights from an interrupted time series analysis. Bone marrow transplantation. 2025.04; ( PubMed , DOI )

  20. Yu Uemura, Masahide Yamamoto, Masataka Ishimura, Hirokazu Kanegane, Akihisa Sawada, Akihiro Hirakawa, Ken-Ichi Imadome, Mayumi Yoshimori, Masashi Nagata, Kouhei Yamamoto, Norio Shimizu, Ryuji Koike, Ayako Arai: JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study. Blood Neoplasia. 2025.02; 2 (1): 100053. ( PubMed , DOI )

  21. Fabian P Suchy, Daiki Karigane, Yusuke Nakauchi, Maimi Higuchi, Jinyu Zhang, Katja Pekrun, Ian Hsu, Amy C Fan, Toshinobu Nishimura, Carsten T Charlesworth, Joydeep Bhadury, Toshiya Nishimura, Adam C Wilkinson, Mark A Kay, Ravindra Majeti, Hiromitsu Nakauchi: Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors. Nat Biotechnol. 2025.02; 43 (2): 204-213. ( PubMed , DOI )

  1. Yotaro Motomura, Kota Yoshifuji, Keisuke Tanaka, Chizuko Sakashita, Yoshihiro Umezawa, Toshikage Nagao, Sayuri Nitta, Yasuhiro Asahina, Takehiko Mori, Masahide Yamamoto: Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma. J Clin Exp Hematop. 2024.12; 64 (4): 313-317. ( PubMed , DOI )

  2. Yusuke Kubota, Masatoshi Sakurai, Yasuhito Nannya, Yasunori Kogure, Kohei Shiroshita, Shinya Fujita, Kentaro Yamaguchi, Kota Mizuno, Jun Kato, Takehiko Mori, Seishi Ogawa, Keisuke Kataoka: Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood. Ann Hematol. 2024.12; 103 (12): 5989-5998. ( PubMed , DOI )

  3. Inoue K, Tomomasa D, Nakagama Y, Takeuchi H, Tanaka Y, Tanimoto K, Kamiya T, Isoda T, Takagi M, Tanaka K, Yoshifuji K, Miwa Y, Ohnishi H, Okada S, Mori T, Yasuda S, Kido Y, Morio T, Kanegane H: Real-world experience of tixagevimab/cilgavimab prophylaxis in Japanese patients with immunodeficiency. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024.12; 31 (2): 102577. ( PubMed , DOI )

  4. Sugimoto Y, Nagaharu K, Ohya E, Ohishi K, Tawara I, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Saito AM, Shimoda K, Kurokawa T, Tomita A, Edahiro Y, Hashimoto Y, Kiyoi H, Akashi K, Matsumura I, Takenaka K, Komatsu N: Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in Japan. International journal of hematology. 2024.12; 120 (6): 684-693. ( PubMed , DOI )

  5. Morikawa R, Nitta K, Yasuda S, Kano Y, Noji R, Aoyama S, Sato S, Ikeda S, Okamoto R, Nagata M, Mori T, Suenaga M: Identification of risk factors for gastrointestinal immune-related adverse events associated with immune check point inhibitors. Expert opinion on drug safety. 2024.12; ( PubMed , DOI )

  6. Momo Wakui, Junichi Tsuchiya, Chikara Kase, Kota Yokoyama, Masahide Yamamoto, Ukihide Tateishi: Comparative Study of Metabolic Tumor Volume in Multiple Myeloma and Related Plasma Cell Dyscrasias: 11C-Acetate PET vs. 18F-FDG PET. Cureus. 2024.10; 16 (10): e71605. ( PubMed , DOI )

  7. Nogami, A; Amemiya, HJ; Fujiwara, H; Umezawa, Y; Tohda, S; Nagao, T: Targeting USP14/UCHL5: A Breakthrough Approach to Overcoming Treatment-Resistant FLT3-ITD-Positive AML INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024.10; 25 (19): ( PubMed , DOI )

  8. Keiki Nagaharu, Eiko Ohya, Yoko Edahiro, Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, Hideho Wada, Kensuke Usuki, Takayuki Tanaka, Takehiko Mori, Satoshi Wakita, Toshiki I Saito, Akiko M Saito, Kazuya Shimoda, Toshiro Kurokawa, Akihiro Tomita, Hitoshi Kiyoi, Koichi Akashi, Itaru Matsumura, Katsuto Takenaka, Norio Komatsu, Kohshi Ohishi, Isao Tawara, Yuka Sugimoto: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis. Ann Hematol. 2024.09; 103 (9): 3535-3541. ( PubMed , DOI )

  9. Satoshi Kaito, Yuho Najima, Daichi Sadato, Chizuko Hirama, Yuya Kishida, Akihito Nagata, Tatsuya Konishi, Yuta Yamada, Shuhei Kurosawa, Kota Yoshifuji, Shuichi Shirane, Naoki Shingai, Takashi Toya, Hiroaki Shimizu, Kyoko Haraguchi, Takeshi Kobayashi, Hironori Harada, Yoshiki Okuyama, Yuka Harada, Noriko Doki: Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies. Bone Marrow Transplant. 2024.08; 59 (8): 1169-1175. ( PubMed , DOI )

  10. Akiyama H, Kantarjian H, Jabbour E, Issa G, Haddad FG, Short NJ, Hu S, Ishizawa J, Andreeff M, Sasaki K: Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia. International journal of hematology. 2024.08; 120 (2): 203-211. ( PubMed , DOI )

  11. Shintaro Watanuki, Hiroshi Kobayashi, Yuki Sugiura, Masamichi Yamamoto, Daiki Karigane, Kohei Shiroshita, Yuriko Sorimachi, Takayuki Morikawa, Shinya Fujita, Kotaro Shide, Miho Haraguchi, Shinpei Tamaki, Takumi Mikawa, Hiroshi Kondoh, Hiroyasu Nakano, Kenta Sumiyama, Go Nagamatsu, Nobuhito Goda, Shinichiro Okamoto, Ayako Nakamura-Ishizu, Kazuya Shimoda, Makoto Suematsu, Toshio Suda, Keiyo Takubo: SDHAF1 confers metabolic resilience to aging hematopoietic stem cells by promoting mitochondrial ATP production. Cell Stem Cell. 2024.08; 31 (8): 1145-1161.e15. ( PubMed , DOI )

  12. Kei Mikita, Takehiko Mori, Tamayo Komine, Seiki Kobayashi, Satoshi Iwata, Koichi Suzuki, Naoki Hasegawa: Development of a LAMP method with lateral flow DNA chromatography to diagnose toxoplasmosis in immunocompromised patients. Trop Med Health. 2024.07; 52 (1): 45. ( PubMed , DOI )

  13. Ohwada C, Sakaida E, Takeda Y, Doki N, Igarashi A, Onizuka M, Toyosaki M, Tanaka M, Tachibana T, Kataoka K, Kato J, Fujisawa S, Kato S, Nakasone H, Naganuma K, Saitoh T, Shono K, Hagihara M, Saito T, Usuki K, Mori T, Nakaseko C, Okamoto S, Kanda Y: Survival impact of response within the first year in a multicenter prospective observational study of chronic GVHD in a Japanese cohort. International journal of hematology. 2024.07; 120 (3): 347-355. ( PubMed , DOI )

  14. Akiyama M, Kanayama M, Umezawa Y, Nagao T, Izumi Y, Yamamoto M, Ohteki T: An early regulatory mechanism of hyperinflammation by restricting monocyte contribution. Frontiers in immunology. 2024.07; 15 1398153. ( PubMed , DOI )

  15. Sho Hashiguchi, Dan Tomomasa, Takuro Nishikawa, Shuji Ishikawa, Harumi Akaike, Hidehiko Kobae, Tsuyoshi Shirai, Toshikage Nagao, Kosuke Noma, Satoshi Okada, Kazuhiro Kamuro, Yasuhiro Okamoto, Hirokazu Kanegane: 18q Deletion Syndrome Presenting with Late-Onset Combined Immunodeficiency. J Clin Immunol. 2024.06; 44 (7): 154. ( PubMed , DOI )

  16. Yoshifuji K, Sadato D, Toya T, Motomura Y, Hirama C, Takase H, Yamamoto K, Harada Y, Mori T, Nagao T: Impact of genetic alterations on central nervous system progression of primary vitreoretinal lymphoma. Haematologica. 2024.06; ( PubMed , DOI )

  17. Ryusuke Yamamoto, Nobuhiro Hiramoto, Ayumi Fujimoto, Hirohito Yamazaki, Takehiko Mori, Naoyuki Uchida, Noriko Doki, Jun Kato, Masashi Nishikubo, Shinichi Kako, Tetsuya Nishida, Shuichi Ota, Makoto Onizuka, Tetsuya Eto, Koichi Onodera, Kazuhiro Ikegame, Ken-Ichi Matsuoka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Yasushi Onishi: Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2024.05; 59 (5): 688-691. ( PubMed , DOI )

  18. Pourebrahim R, Montoya RH, Akiyama H, Ostermann L, Khazaei S, Muftuoglu M, Baran N, Zhao R, Lesluyes T, Liu B, Khoury JD, Gagea M, Van Loo P, Andreeff M: Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice. Cell reports. Medicine. 2024.05; 5 (5): 101558. ( PubMed , DOI )

  19. Umezawa Y, Yoshifuji K, Tanaka K, Nogami A, Nagano K, Tsuji A, Nagao T, Yamamoto M, Kajiwara M, Tohda S, Mori T: Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation. Annals of hematology. 2024.05; 103 (5): 1737-1744. ( PubMed , DOI )

  20. Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, Isoda T, Takagi M, Kajiwara M, Azumi S, Hirabayashi S, Sakamoto K, Kishimoto K, Miyamura T, Umeda K, Hirose A, Keino D, Yanagimachi M, Kanda K, Sakai Y, Ikawa Y, Watanabe K, Tanaka K, Mori T, Ichinohe T, Sakaguchi H, Morio T, Kanegane H: Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024.05; 44 (6): 126. ( PubMed , DOI )

  21. Jonas L Fowler, Sherry Li Zheng, Alana Nguyen, Angela Chen, Xiaochen Xiong, Timothy Chai, Julie Y Chen, Daiki Karigane, Allison M Banuelos, Kouta Niizuma, Kensuke Kayamori, Toshinobu Nishimura, M Kyle Cromer, David Gonzalez-Perez, Charlotte Mason, Daniel Dan Liu, Leyla Yilmaz, Lucile Miquerol, Matthew H Porteus, Vincent C Luca, Ravindra Majeti, Hiromitsu Nakauchi, Kristy Red-Horse, Irving L Weissman, Lay Teng Ang, Kyle M Loh: Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells. Developmental Cell. 2024.05; 59 (9): 1110-1131.e22. ( PubMed , DOI )

  22. Akiyama H, Zhao R, Ostermann LB, Li Z, Tcheng M, Yazdani SJ, Moayed A, Pryor ML 2nd, Slngh S, Baran N, Ayoub E, Nishida Y, Mak PY, Ruvolo VR, Carter BZ, Schimmer AD, Andreeff M, Ishizawa J: Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia. Leukemia. 2024.04; 38 (4): 729-740. ( PubMed , DOI )

  23. Akiyama H, Zhao R, Ostermann LB, Li Z, Tcheng M, Yazdani SJ, Moayed A, Pryor ML 2nd, Slngh S, Baran N, Ayoub E, Nishida Y, Mak PY, Ruvolo VR, Carter BZ, Schimmer AD, Andreeff M, Ishizawa J: Correction: Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia. Leukemia. 2024.04; 38 (4): 926. ( PubMed , DOI )

  24. Yotaro Motomura, Kota Yoshifuji, Takayoshi Tachibana, Hiroshi Takase, Ayako Arai, Keisuke Tanaka, Keigo Okada, Ayako Nogami, Yoshihiro Umezawa, Chizuko Sakashita, Masahide Yamamoto, Takehiko Mori, Toshikage Nagao: Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma. Br J Haematol. 2024.04; 204 (4): 1279-1287. ( PubMed , DOI )

  25. Shintaro Watanuki, Hiroshi Kobayashi, Yuki Sugiura, Masamichi Yamamoto, Daiki Karigane, Kohei Shiroshita, Yuriko Sorimachi, Shinya Fujita, Takayuki Morikawa, Shuhei Koide, Motohiko Oshima, Akira Nishiyama, Koichi Murakami, Miho Haraguchi, Shinpei Tamaki, Takehiro Yamamoto, Tomohiro Yabushita, Yosuke Tanaka, Go Nagamatsu, Hiroaki Honda, Shinichiro Okamoto, Nobuhito Goda, Tomohiko Tamura, Ayako Nakamura-Ishizu, Makoto Suematsu, Atsushi Iwama, Toshio Suda, Keiyo Takubo: Context-dependent modification of PFKFB3 in hematopoietic stem cells promotes anaerobic glycolysis and ensures stress hematopoiesis. Elife. 2024.04; 12 ( PubMed , DOI )

  26. Takashi Toya, Kota Mizuno, Masatoshi Sakurai, Jun Kato, Takehiko Mori, Noriko Doki, Shinichi Masuda, Nobuyuki Aotsuka, Shokichi Tsukamoto, Emiko Sakaida, Yuki Nakajima, Shin Fujisawa, Shinichiro Machida, Yasuyuki Aoyama, Hiroki Yokoyama, Katsuhiro Shono, Yoshihiro Hatta, Kensuke Usuki, Keisuke Kataoka, Yoshinobu Kanda: Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis. Blood Adv. 2024.03; 8 (5): 1084-1093. ( PubMed , DOI )

  27. Kawade G, Kurata M, Matsuki Y, Fukuda S, Onishi I, Kinowaki Y, Watabe S, Ishibashi S, Ikeda M, Yamamoto M, Ohashi K, Kitagawa M, Yamamoto K: Mediation of FSP1 expression via 4-HNE accumulation contributes to acquisition of resistance to apoptosis and ferroptosis in DLBCL. Laboratory investigation; a journal of technical methods and pathology. 2024.02; 102027. ( PubMed , DOI )

  28. Hikaru Aoki, Yasunari Miyazaki, Tatsuhiko Anzai, Kota Yokoyama, Junichi Tsuchiya, Tsuyoshi Shirai, Sho Shibata, Rie Sakakibara, Takahiro Mitsumura, Takayuki Honda, Haruhiko Furusawa, Tsukasa Okamoto, Tomoya Tateishi, Meiyo Tamaoka, Masahide Yamamoto, Kunihiko Takahashi, Ukihide Tateishi, Tetsuo Yamaguchi: Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [18F]FDG maximum-intensity projection images Eur Radiol. 2024.01; 34 (1): 374-383. ( PubMed , DOI )

  29. Noriharu Nakagawa, Ken Ishiyama, Kensuke Usuki, Satoru Takada, Tatsuki Tomikawa, Hiroshi Handa, Yuna Katsuoka, Daiki Hirano, Nobuo Sezaki, Masahiko Sumi, Shin Fujisawa, Yasuhiro Taniguchi, Atsuko Mugitani, Takuro Yoshimura, Eiichi Ohtsuka, Ken Takase, Youko Suehiro, Shuichi Ota, Tomohiro Kajiguchi, Tomoya Maeda, Masahide Yamamoto, Shigeki Ohtake, Akira Katsumi, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki: Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT. Ann Hematol. 2024.01; 103 (1): 307-320. ( PubMed , DOI )

  30. Niklas Landberg, Thomas Köhnke, Yang Feng, Yusuke Nakauchi, Amy C Fan, Miles H Linde, Daiki Karigane, Kelly Lim, Rahul Sinha, Luca Malcovati, Daniel Thomas, Ravindra Majeti: IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation. Blood Cancer Discovery. 2024.01; OF1-OF18. ( PubMed , DOI )

  1. Onishi Y, Mori T, Yamazaki H, Hiramoto N, Zaimoku Y, Kanaya M, Matsue K, Onizuka M, Aotsuka N, Uchida N, Onodera K, Kanda J, Nakamae H, Yamamoto R, Kuriyama T, Kimura T, Ichinohe T, Atsuta Y, Adult Aplastic Anemia Working Group of the Japanese Society for Transplantation and Cellular Therapy: Comparison of haploidentical stem cell transplantation with post-transplant cyclophosphamide versus umbilical cord blood transplantation in adult patients with aplastic anemia. Transplantation and cellular therapy. 2023.12; 29 (12): 766.e1-766.e8. ( PubMed , DOI )

  2. Yusuke Nakauchi, Asiri Ediriwickrema, Daniel Martinez-Krams, Feifei Zhao, Athreya Rangavajhula, Daiki Karigane, Ravindra Majeti: Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis. Journal of Visualized Experiments. 2023.11; (201): ( PubMed , DOI )

  3. Kako S, Kimura SI, Wada H, Komiya Y, Nakasone H, Sakurai M, Kato J, Tanaka M, Fujii E, Tachibana T, Yamamoto W, Hagihara M, Watanabe R, Yokota A, Nakano H, Mori T, Nakaseko C, Kanamori H, Okamoto S, Kanda Y: Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study. Leukemia research. 2023.10; 133 107371. ( PubMed , DOI )

  4. Asuka Kono, Manabu Wakamatsu, Yoshihiro Umezawa, Hideki Muramatsu, Hiroki Fujiwara, Dan Tomomasa, Kento Inoue, Keiichiro Hattori, Tetsuo Mitsui, Hidetoshi Takada, Yoshiyuki Minegishi, Yoshiyuki Takahashi, Masahide Yamamoto, Takehiko Mori, Hirokazu Kanegane: Successful treatment of DOCK8 deficiency by allogeneic hematopoietic cell transplantation from alternative donors. Int J Hematol. 2023.10; 118 (4): 519-525. ( PubMed , DOI )

  5. Fujita S, Kasahara H, Kato J, Koda Y, Shiroshita K, Yamaguchi K, Okayama M, Abe R, Kikuchi T, Shimizu T, Mori T, Kataoka K, Okamoto S: The Impact of Pretransplant Use of Tyrosine Kinase Inhibitors on Allogeneic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia-A Single-institution Retrospective Study. Internal medicine (Tokyo, Japan). 2023.10; 63 (11): 1549-1562. ( PubMed , DOI )

  6. Shimizu H, Najima Y, Kako S, Tanaka M, Fujiwara SI, Mori T, Usuki K, Gotoh M, Hagihara M, Tsukada N, Oniduka M, Takada S, Sakaida E, Fujisawa S, Onoda M, Aotsuka N, Yano S, Ohashi K, Takahashi S, Okamoto S, Kanda Y, Kanto Study Group for Cell Therapy (KSGCT): Clinical significance of late CMV disease in adult patients who underwent allogeneic stem cell transplant. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023.10; 29 (12): 1103-1108. ( PubMed , DOI )

  7. Amy C Fan, Yusuke Nakauchi, Lawrence Bai, Armon Azizi, Kevin A Nuno, Feifei Zhao, Thomas Köhnke, Daiki Karigane, David Cruz-Hernandez, Andreas Reinisch, Purvesh Khatri, Ravindra Majeti: RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition. Journal of Clinical Investigation. 2023.10; 133 (19): ( PubMed , DOI )

  8. Kohei Shiroshita, Hiroshi Kobayashi, Shintaro Watanuki, Daiki Karigane, Yuriko Sorimachi, Shinpei Tamaki, Miho Haraguchi, Masamichi Yamamoto, Ayako Nakamura-Ishizu, Shinichiro Okamoto, Keisuke Kataoka, Keiyo Takubo: Distinct roles of the preparatory and payoff phases of glycolysis in hematopoietic stem cells. Experimental Hematology. 2023.08; 124 56-67. ( PubMed , DOI )

  9. Tomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama, Keiko Fujii, Tomoko Henzan, Kaoru Kahata, Rie Yamazaki, Wataru Takeda, Yoshihiro Umezawa, Kentaro Fukushima, Takashi Ashida, Minami Yamada-Fujiwara, Ryo Hanajiri, Noboru Yonetani, Yuma Tada, Yuji Shimura, Hidekazu Nishikii, Norio Shiba, Naoya Mimura, Jun Ando, Takayuki Sato, Yasuhiro Nakashima, Junko Ikemoto, Keita Iwaki, Shin-Ichiro Fujiwara, Masaki Ri, Tokiko Nagamura-Inoue, Ryuji Tanosaki, Yasuyuki Arai: Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan. Br J Haematol. 2023.07; 202 (2): 256-266. ( PubMed , DOI )

  10. Okinaka K, Inoue Y, Uchida N, Toya T, Ogawa H, Ozawa Y, Eto T, Mori T, Sugita J, Kondo T, Kato K, Suzuki R, Fukuda T: Clinical characteristics and risk factors of pneumococcal diseases in recipients of allogeneic hematopoietic stem cell transplants in the late phase: A retrospective registry study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023.07; 29 (7): 726-730. ( PubMed , DOI )

  11. Akiyama H, Carter BZ, Andreeff M, Ishizawa J: Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and Leukemia. Cells. 2023.04; 12 (8): ( PubMed , DOI )

  12. Harada K, Onizuka M, Mori T, Shimizu H, Seo S, Aotsuka N, Takeda Y, Sekiya N, Kusuda M, Fujihara S, Shiraiwa S, Shono K, Shingai N, Kanamori H, Momoki M, Takada S, Mukae J, Masuda S, Mitani K, Sakaida E, Tomikawa T, Takahashi S, Usuki K, Kanda Y: Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A KSGCT Multicenter Analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2023.03; 131 79-86. ( PubMed , DOI )

  13. Yoshihiro Umezawa, Koji Sasaki: Dose optimization of tyrosine kinase inhibitor therapy in chronic myeloid leukemia. Int J Hematol. 2023.01; 117 (1): 24-29. ( PubMed , DOI )

  14. Kanda Y, Mori T, Narita A, Wolter KD, Yoshimatsu H, Nishimura K: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series. International journal of hematology. 2023.01; 117 (3): 469. ( PubMed , DOI )

  1. Nagao T, Yoshifuji K, Sadato D, Motomura Y, Saito M, Yamamoto K, Yamamoto K, Nogami A: Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12. Experimental hematology. 2022.12; 116 37-49. ( PubMed , DOI )

  2. Kimura Shunichi, Shimizu Hiroaki, Miyazaki Takuya, Sakurai Masatoshi, Tanoue Susumu, Kayamori Kensuke, Ohwada Chikako, Yoshimura Kazuki, Nakasone Hideki, Ohashi Takuma, Shono Katsuhiro, Tachibana Takayoshi, Hatano Kaoru, Okada Keigo, Kimura Yuta, Seo Sachiko, Doki Noriko, Tanaka Masatsugu, Hatta Yoshihiro, Takahashi Satoshi, Kanda Yoshinobu: Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation BONE MARROW TRANSPLANTATION. 2022.12; ( PubMed , DOI )

  3. Nagao T, Yoshifuji K, Sadato D, Motomura Y, Saito M, Yamamoto K, Yamamoto K, Nogami A: Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12. Experimental hematology. 2022.12; 116 37-49. ( PubMed , DOI )

  4. Kohei Shiroshita, Hiroshi Kobayashi, Shintaro Watanuki, Daiki Karigane, Yuriko Sorimachi, Shinya Fujita, Shinpei Tamaki, Miho Haraguchi, Naoki Itokawa, Kazumasa Aoyoama, Shuhei Koide, Yosuke Masamoto, Kenta Kobayashi, Ayako Nakamura-Ishizu, Mineo Kurokawa, Atsushi Iwama, Shinichiro Okamoto, Keisuke Kataoka, Keiyo Takubo: A culture platform to study quiescent hematopoietic stem cells following genome editing. Cell Reports Methods. 2022.12; 2 (12): 100354. ( PubMed , DOI )

  5. Nakamura Y, Mori T, Kako S, Yamazaki H, Kanda Y, Uchida N, Tanaka M, Nawa Y, Fukuda T, Ichinohe T, Atsuta Y, Onishi Y: Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia. International journal of hematology. 2022.11; 117 (3): 356-365. ( PubMed , DOI )

  6. Yoshifuji Kota, Sasaki Koji: Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia FRONTIERS IN ONCOLOGY. 2022.10; 12 1021662. ( PubMed , DOI )

  7. Nogawa M, Watanabe N, Koike T, Fukuda K, Ishiguro M, Fujino H, Hirayama J, Shiba M, Handa M, Mori T, Okamoto S, Miyata S, Satake M.: Hemostatic function of cold‐stored platelets in a thrombocytopenic rabbit bleeding model Transfusion. 2022.09; 62 (11): 2304-2313. ( PubMed , DOI )

  8. Yokoyama Y, Nozawa E, Morita M, Ishikawa E, Mori T, Sakurai M, Kikuchi T, Matsuki E, Yamazaki R, Kataoka K, Jibiki A, Kawazoe H, Suzuki S, Nakamura T: Simultaneous quantification of dasatinib, nilotinib, bosutinib, and ponatinib using high-performance liquid chromatography-Photodiode array detection. Journal of clinical laboratory analysis. 2022.08; 36 (8): e24598. ( PubMed , DOI )

  9. Fukuhara Suguru, Oshikawa-Kumade Yuji, Kogure Yasunori, Shingaki Sumito, Kariyazono Hirokazu, Kikukawa Yoshiya, Koya Junji, Saito Yuki, Tabata Mariko, Yoshifuji Kota, Mizuno Kota, Miyagi-Maeshima Akiko, Matsushita Hiromichi, Sugiyama Masanaka, Ogawa Chitose, Inamoto Yoshihiro, Fukuda Takahiro, Sugano Masato, Yamauchi Nobuhiko, Minami Yosuke, Hirata Makoto, Yoshida Teruhiko, Kohno Takashi, Kohsaka Shinji, Mano Hiroyuki, Shiraishi Yuichi, Ogawa Seishi, Izutsu Koji, Kataoka Keisuke: Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies CANCER SCIENCE. 2022.08; 113 (8): 2763-2777. ( DOI )

  10. Noji R, Tohyama K, Kugimoto T, Kuroshima T, Hirai H, Tomioka H, Michi Y, Tasaki A, Ohno K, Ariizumi Y, Onishi I, Suenaga M, Mori T, Okamoto R, Yoshimura R, Miura M, Asakage T, Miyake S, Ikeda S, Harada H, Kano Y: Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer. Cancers. 2022.07; 14 (14): ( PubMed , DOI )

  11. Mizuno K, Sakurai M, Kato J, Yamaguchi K, Abe R, Koda Y, Kataoka K, Mori T: Risk factor analysis for cytomegalovirus reactivation under prophylaxis with letermovir after allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society. 2022.07; 24 (6): e13904. ( PubMed , DOI )

  12. Edahiro Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Kada A, Saito AM, Shimoda K, Sugimoto Y, Kurokawa T, Tomita A, Hashimoto Y, Akashi K, Matsumura I, Takenaka K, Komatsu N: Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study. International journal of hematology. 2022.07; 116 (5): 696-711. ( PubMed , DOI )

  13. Yusuke Nakauchi, Armon Azizi, Daniel Thomas, M Ryan Corces, Andreas Reinisch, Rajiv Sharma, David Cruz Hernandez, Thomas Köhnke, Daiki Karigane, Amy Fan, Daniel Martinez-Krams, Melissa Stafford, Satinder Kaur, Ritika Dutta, Paul Phan, Asiri Ediriwickrema, Erin McCarthy, Yuhong Ning, Tierney Phillips, Christopher K Ellison, Gulfem D Guler, Anna Bergamaschi, Chin-Jen Ku, Samuel Levy, Ravindra Majeti: The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia. Blood Cancer Discovery. 2022.07; 3 (4): 346-367. ( PubMed , DOI )

  14. Yokota T, Ueno T, Soga Y, Ishiki H, Uezono Y, Mori T, Zenda S, Uchitomi Y.: J-SUPPORT research policy for oral mucositis associated with cancer treatment Cancer Med. 2022.06; 11 (24): 4816-4829. ( PubMed , DOI )

  15. Masahide Yamamoto, Maho Sato, Yasushi Onishi, Yoji Sasahara, Hideki Sano, Masayoshi Masuko, Hirohisa Nakamae, Ken-Ichi Matsuoka, Takahide Ara, Kana Washio, Makoto Onizuka, Kenichiro Watanabe, Yoshiyuki Takahashi, Tsuneaki Hirakawa, Miwako Nishio, Chizuko Sakashita, Tohru Kobayashi, Akihisa Sawada, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Hashii, Yoshiko Atsuta, Ayako Arai: Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein-Barr virus infection patients in Japan. Am J Hematol. 2022.06; 97 (6): 780-790. ( PubMed , DOI )

  16. Satoru Aoyama, Shunichiro Yasuda, Huixin Li, Daisuke Watanabe, Yoshihiro Umezawa, Keigo Okada, Ayako Nogami, Osamu Miura, Norihiko Kawamata: A novel chimeric antigen receptor (CAR) system using an exogenous protease, in which activation of T cells is controlled by expression patterns of cell‑surface proteins on target cells. International Journal of Molecular Medicine. 2022.04; 49 (4): ( PubMed , DOI )

  17. Tsuyoshi Nakagawa, Kumiko Hayashi, Ayumi Ogawa, Goshi Oda, Iichiro Onishi, Masahide Yamamoto, Mio Mori, Tomoyuki Fujioka, Toshiaki Ishikawa, Kentaro Okamoto, Hiroyuki Uetake: Bone Marrow Carcinomatosis in a Stage IV Breast Cancer Patient Treated by Letrozole as First-Line Endocrine Therapy. Case Rep Oncol. 2022.04; 15 (1): 436-441. ( PubMed , DOI )

  18. Sekiya T, Kasahara H, Takemura R, Fujita S, Kato J, Doki N, Katayama Y, Ozawa Y, Takada S, Eto T, Fukuda T, Ichinohe T, Takanashi M, Onizuka M, Atsuta Y, Okamoto S, Yoshimura A, Takaki S, Mori T: Essential Roles of the Transcription Factor NR4A1 in Regulatory T Cell Differentiation under the Influence of Immunosuppressants. Journal of immunology (Baltimore, Md. : 1950). 2022.04; 208 (9): 2122-2130. ( PubMed , DOI )

  19. Karigane D, Haraguchi M, Toyama-Sorimachi N, Nishimura EK, Takubo K: Mitf is required for T cell maturation by regulating dendritic cell homing to the thymus. Biochemical and biophysical research communications. 2022.03; 596 29-35. ( PubMed , DOI )

  20. Tachibana T, Kondo T, Uchida N, Doki N, Takada S, Takahashi S, Yano S, Mori T, Kohno A, Kimura T, Fukuda T, Atsuta Y, Nagamura-Inoue T, On-Behalf-Of-The-Adult-Cmlmpn-Working-Group-Of-The-Japanese-Society-For-Transplantation-And-Cellular-Therapy: The clinical significance of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive chronic myeloid leukemia who underwent allogeneic hematopoietic cell transplantation. Transplantation and cellular therapy. 2022.03; 28 (6): 321.e1-321.e8. ( PubMed , DOI )

  21. Fumiya Wada, Mizuki Watanabe, Takaaki Konuma, Motohito Okabe, Shinichi Kobayashi, Naoyuki Uchida, Kazuhiro Ikegame, Masatsugu Tanaka, Yasuhiro Sugio, Junichi Mukae, Makoto Onizuka, Toshiro Kawakita, Takuro Kuriyama, Satoshi Takahashi, Takahiro Fukuda, Nobuaki Nakano, Masashi Sawa, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda, : HLA 1-3 antigen-mismatched related peripheral blood stem cells transplantation using low-dose antithymocyte globulin versus unrelated cord blood transplantation. Am J Hematol. 2022.03; 97 (3): 311-321. ( PubMed , DOI )

  22. Hashimoto Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Kada A, Saito AM, Shimoda K, Sugimoto Y, Kurokawa T, Tomita A, Edahiro Y, Akashi K, Matsumura I, Takenaka K, Komatsu N.: Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study Int J Hematol. . 2022.02; 115 208-221.

  23. Takase H, Arai A, Iwasaki Y, Imai A, Nagao T, Kawagishi M, Ishida T, Mochizuki M: Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches. Progress in retinal and eye research. 2022.02; 90 101053. ( PubMed , DOI )

  24. Hashimoto Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Kada A, Saito AM, Shimoda K, Sugimoto Y, Kurokawa T, Tomita A, Edahiro Y, Akashi K, Matsumura I, Takenaka K, Komatsu N: Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study. International journal of hematology. 2022.02; 115 (2): 208-221. ( PubMed , DOI )

  25. Aya Usami, Kota Yokoyama, Junichi Tsuchiya, Yoshihiro Umezawa, Kazuma Toda, Ukihide Tateishi, Ryoichi Yoshimura: F]FDG Avidity and Low EOB Uptake Proportional to the Irradiation Dose. Diagnostics (Basel). 2022.02; 12 (2): ( PubMed , DOI )

  26. Kogure Yasunori, Kameda Takuro, Koya Junji, Yoshimitsu Makoto, Nosaka Kisato, Yasunaga Jun-ichirou, Imaizumi Yoshitaka, Watanabe Mizuki, Saito Yuki, Ito Yuta, McClure Marni B., Tabata Mariko, Shingaki Sumito, Yoshifuji Kota, Chiba Kenichi, Okada Ai, Kakiuchi Nobuyuki, Nannya Yasuhito, Kamiunten Ayako, Tahira Yuki, Akizuki Keiichi, Sekine Masaaki, Shide Kotaro, Hidaka Tomonori, Kubuki Yoko, Kitanaka Akira, Hidaka Michihiro, Nakano Nobuaki, Utsunomiya Atae, Sica R. Alejandro, Acuna-Villaorduna Ana, Janakiram Murali, Shah Urvi, Ramos Juan Carlos, Shibata Tatsuhiro, Takeuchi Kengo, Takaori-Kondo Akifumi, Miyazaki Yasushi, Matsuoka Masao, Ishitsuka Kenji, Shiraishi Yuichi, Miyano Satoru, Ogawa Seishi, Ye B. Hilda, Shimoda Kazuya, Kataoka Keisuke: Whole-genome landscape of adult T-cell leukemia/lymphoma BLOOD. 2022.02; 139 (7): 967-982.

  27. Nobuhiro Hiramoto, Hirohito Yamazaki, Yukinori Nakamura, Naoyuki Uchida, Makoto Murata, Tadakazu Kondo, Satoshi Yoshioka, Tetsuya Eto, Akinori Nishikawa, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Yasushi Onishi, Ritsuro Suzuki, Takehiko Mori, : Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation. Ann Hematol. 2022.01; 101 (1): 165-175. ( PubMed , DOI )

  28. Takehiko Mori, Yuya Koda, Jun Kato, Masatoshi Sakurai, Yoshifumi Uwamino, Naoki Hasegawa: Usefulness of the FilmArray Meningitis/Encephalitis Panel in diagnosis of central nervous system infection after allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2022.01; 30 (1): 5-8. ( PubMed , DOI )

  29. Kawajiri A, Kawase T, Tanaka H, Fukuda T, Mukae J, Ozawa Y, Eto T, Uchida N, Mori T, Ashida T, Kondo T, Onizuka M, Ichinohe T, Atsuta Y, Morishima S, Kanda J, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation. Bone marrow transplantation. 2022.01; 57 (3): 407-415. ( PubMed , DOI )

  30. Masatoshi Sakurai, Yasuhito Nannya, Rie Yamazaki, Kentaro Yamaguchi, Yuya Koda, Ryohei Abe, Kenji Yokoyama, Seishi Ogawa, Takehiko Mori: Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies. Ann Hematol. 2022.01; 101 (1): 237-239. ( PubMed , DOI )

  31. Hirohisa Nakamae, Masahide Yamamoto, Emiko Sakaida, Yoshinobu Kanda, Ken Ohmine, Takaaki Ono, Itaru Matsumura, Maho Ishikawa, Makoto Aoki, Akio Maki, Hirohiko Shibayama: Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial. Int J Hematol. 2022.01; 115 (1): 33-42. ( PubMed , DOI )

  1. Efficacy of ondansetron against emesis induced by a multiple-day cisplatin-based chemotherapy regimen for malignant lymphoma Hematology. 2021.12; 26 (1): 945-949.

  2. Kamiya T, Sakurai M, Kikuchi T, Okayama M, Mizuno K, Tanigawa T, Koda Y, Kato J, Mori T: Efficacy of ondansetron against emesis induced by a multiple-day cisplatin-based chemotherapy regimen for malignant lymphoma. Hematology (Amsterdam, Netherlands). 2021.12; 26 (1): 945-949. ( PubMed , DOI )

  3. Masamichi Isobe, Takaaki Konuma, Maki Monna-Oiwa, Motohito Okabe, Seiko Kato, Satoshi Takahashi, Arinobu Tojo: Momentum of neutrophil recovery using an exponential growth model predicts the prognosis of single cord blood transplantation. Int J Lab Hematol. 2021.12; 43 (6): 1465-1471. ( PubMed , DOI )

  4. Yuta Kaito, Takaaki Konuma, Maki Monna-Oiwa, Seiko Kato, Masamichi Isobe, Motohito Okabe, Yoichi Imai, Satoshi Takahashi, Arinobu Tojo: Prognostic impacts of peripheral blood erythroblasts after single-unit cord blood transplantation. Int J Lab Hematol. 2021.12; 43 (6): 1437-1442. ( PubMed , DOI )

  5. Takayoshi Tachibana, Junya Kanda, Takuma Ishizaki, Yuho Najima, Masatsugu Tanaka, Noriko Doki, Shin-Ichiro Fujiwara, Shun-Ichi Kimura, Makoto Onizuka, Satoshi Takahashi, Takeshi Saito, Takehiko Mori, Shin Fujisawa, Emiko Sakaida, Takuya Miyazaki, Nobuyuki Aotsuka, Moritaka Gotoh, Reiko Watanabe, Katsuhiro Shono, Heiwa Kanamori, Yoshinobu Kanda, Shinichiro Okamoto, : Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis Ann Hematol. 2021.11; 100 (11): 2763-2771. ( PubMed , DOI )

  6. Shunichiro Yasuda, Satoru Aoyama, Ryoto Yoshimoto, Huixin Li, Daisuke Watanabe, Hiroki Akiyama, Kouhei Yamamoto, Takeo Fujiwara, Yuho Najima, Noriko Doki, Emiko Sakaida, Yoko Edahiro, Misa Imai, Marito Araki, Norio Komatsu, Osamu Miura, Norihiko Kawamata: MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations. Int J Hematol. 2021.10; 114 (4): 424-440. ( PubMed , DOI )

  7. Comparison of cord blood and HLA mismatched related transplantation using antithymocyte globulin(和訳中) 2021.09; 83回 OS1-2. ( ichushi )

  8. Yuji Sekine, Kouhei Yamamoto, Morito Kurata, Ayaka Honda, Iichiroh Onishi, Yuko Kinowaki, Genji Kawade, Shiori Watabe, Serina Nomura, Sho Fukuda, Sachiko Ishibashi, Masumi Ikeda, Masahide Yamamoto, Masanobu Kitagawa: HADHB, a fatty acid beta-oxidation enzyme, is a potential prognostic predictor in malignant lymphoma. Pathology. 2021.09; (21): 435-439. ( PubMed , DOI )

  9. Nishida Y, Zhao R, Heese LE, Akiyama H, Patel S, Jaeger AM, Jacamo RO, Kojima K, Ma MCJ, Ruvolo VR, Chachad D, Devine W, Lindquist S, Davis RE, Porco JA Jr, Whitesell L, Andreeff M, Ishizawa J: Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML. Leukemia. 2021.09; 35 (9): 2469-2481. ( PubMed , DOI )

  10. Hideki Nakasone, Shinichi Kako, Takayoshi Tachibana, Masatsugu Tanaka, Makoto Onizuka, Satoshi Takahashi, Akira Yokota, Shin-Ichiro Fujiwara, Toru Sakura, Emiko Sakaida, Shin Fujisawa, Rie Yamazaki, Moritaka Gotoh, Maki Hagihara, Nobuyuki Aotsuka, Nobuhiro Tsukada, Yoshihiro Hatta, Hiroaki Shimizu, Kensuke Usuki, Reiko Watanabe, Takehiko Mori, Shingo Yano, Heiwa Kanamori, Yoshinobu Kanda: Novel Indicators of Transplant Outcomes for PhALL: Current Molecular-Relapse-Free Survival. Transplant Cell Ther. 2021.09; 27 (9): 800.e1-800.e8. ( PubMed , DOI )

  11. Takaaki Konuma, Maki Monna-Oiwa, Masamichi Isobe, Motohito Okabe, Satoshi Takahashi, Arinobu Tojo: Radiation-free myeloablative conditioning consisting of fludarabine added to full-dose busulfan and cyclophosphamide in single-unit cord blood transplantation for adults. Eur J Haematol. 2021.09; 107 (3): 374-376. ( PubMed , DOI )

  12. Shunichiro Yasuda, Yuho Najima, Tatsuya Konishi, Yuta Yamada, Akihito Nagata, Toshiaki Takezaki, Satoshi Kaito, Shuhei Kurosawa, Masahiro Sakaguchi, Kaito Harada, Naoki Shingai, Kosuke Yoshioka, Kyoko Inamoto, Junichi Mukae, Takashi Toya, Aiko Igarashi, Hiroaki Shimizu, Takeshi Kobayashi, Kazuhiko Kakihana, Hisashi Sakamaki, Norihiko Kawamata, Kazuteru Ohashi, Noriko Doki: Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study. Leuk Res. 2021.09; 108 106627. ( PubMed , DOI )

  13. Saiko Kurosawa, Takuhiro Yamaguchi, Ayako Mori, Tomoko Matsuura, Takehiko Mori, Masatsugu Tanaka, Tadakazu Kondo, Yukari Umemoto, Hideki Goto, Satoshi Yoshioka, Shinichiro Machida, Takahiko Sato, Yuta Katayama, Seiko Kato, Katsuhiro Shono, Ishikazu Mizuno, Shin-Ichiro Fujiwara, Akio Kohno, Miyako Takahashi, Takahiro Fukuda: Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up. J Cancer Surviv. 2021.08; 16 (5): 1004-1015. ( PubMed , DOI )

  14. Ikuko Hirai, Takeru Funakoshi, Hajime Kamijuku, Keitaro Fukuda, Mariko Mori, Masatoshi Sakurai, Yuya Koda, Jun Kato, Takehiko Mori, Naohide Watanabe, Shinobu Noji, Tomonori Yaguchi, Takashi Iwata, Shigeki Ohta, Tomonobu Fujita, Ryuji Tanosaki, Makoto Handa, Shinichiro Okamoto, Masayuki Amagai, Yutaka Kawakami: Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors. Cancer Sci. 2021.08; 112 (8): 3163-3172. ( PubMed , DOI )

  15. Konishi Tatsuya, Kusakabe Shinsuke, Hino Akihisa, Inamoto Kyoko, Yoshifuji Kota, Kiridoshi Yuko, Takeshita Kozue, Sasajima Satoshi, Toya Takashi, Igarashi Aiko, Najima Yuho, Kobayashi Takeshi, Doki Noriko, Motooka Daisuke, Nakamura Shota, Suyama Masahiro, Suda Wataru, Shiota Atsushi, Atarashi Koji, Hattori Masahira, Honda Kenya, Yokota Takafumi, Ohashi Kazuteru, Shibayama Hirohiko, Fukushima Kentaro, Kakihana Kazuhiko: Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease BONE MARROW TRANSPLANTATION. 2021.07; 56 (7): 1728-1731. ( DOI )

  16. Motohito Okabe, Takanobu Morishita, Takahiko Yasuda, Hirotoshi Sakaguchi, Masashi Sanada, Keisuke Kataoka, Seishi Ogawa, Yuichi Shiraishi, Tomoe Ichiki, Yuka Kawaguchi, Marie Ohbiki, Rena Matsumoto, Masahide Osaki, Tatsunori Goto, Yukiyasu Ozawa, Koichi Miyamura: Targeted deep next generation sequencing identifies potential somatic and germline variants for predisposition to familial Burkitt lymphoma. Eur J Haematol. 2021.07; 107 (1): 166-169. ( PubMed , DOI )

  17. Yasuda S, Aoyama S, Yoshimoto R, Li H, Watanabe D, Akiyama H, Yamamoto K, Fujiwara T, et al: MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations Int J Hematol. 2021.06; ( PubMed , DOI )

  18. Kota Yoshifuji, Takashi Toya, Noriyo Yanagawa, Fumikazu Sakai, Akihito Nagata, Noritaka Sekiya, Kazuteru Ohashi, Noriko Doki: CT classification of acute myeloid leukemia with pulmonary infiltration Japanese Journal of Radiology. 2021.06; 39 (11): 1049-1058. ( PubMed , DOI )

  19. Mori T, Kikuchi T, Koh M, Koda Y, Yamazaki R, Sakurai M, Tomita Y, Ozawa Y, Kohashi S, Abe R, Saburi M, Kato J: Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening. Bone marrow transplantation. 2021.06; 56 (6): 1266-1271. ( PubMed , DOI )

  20. Uno S, Takano Y, Iketani O, Abiko T, Miwa T, Nanki K, Kurihara T, Tamura Y, Ara M, Uwamino Y, Shinjoh M, Mori T, Hasegawa N: Digestive Decolonization of Colorectal Carriage of Vancomycin-resistant Enterococcus faecium in a Japanese Adult: A Case Report. Internal medicine . 2021.06; 61 (2): 249-252. ( PubMed , DOI )

  21. Sakurai M, Mori T, Kato K, Kanaya M, Mizuno S, Shiratori S, Wakayama T, Uchida N, Kobayashi H, Kubo K, Amano I, Ohta T, Miyazaki Y, Kanda J, Fukuda T, Atsuta Y, Kondo E, Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).: Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation. Bone marrow transplantation. 2021.06; 56 (6): 1462-1466. ( PubMed , DOI )

  22. Mori T, Kikuchi T, Yamazaki R, Koda Y, Saburi M, Sakurai M, Shigematsu N, Okamoto S, Kato J: Phase 1 study of plerixafor in combination with total body irradiation-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation. International journal of hematology. 2021.06; 113 (6): 877-883. ( PubMed , DOI )

  23. Nakasone H, Kako S, Mori T, Takahashi S, Onizuka M, Fujiwara SI, Sakura T, Sakaida E, Yokota A, Aotsuka N, Hagihara M, Tsukada N, Hatta Y, Usuki K, Watanabe R, Gotoh M, Fujisawa S, Yano S, Kanamori H, Okamoto S, Kanda Y: Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia. Bone marrow transplantation. 2021.06; 56 (6): 1402-1412. ( PubMed , DOI )

  24. Amikura T, Kikuchi T, Kato J, Koda Y, Sakurai M, Yamazaki R, Mikita K, Saburi M, Nakazato T, Mori T: Toxoplasmosis after allogeneic hematopoietic stem cell transplantation: Impact of serostatus-based management. Transplant infectious disease : an official journal of the Transplantation Society. 2021.06; 23 (3): e13506. ( PubMed , DOI )

  25. Masayuki Nagasawa, Noriko Mitsuiki, Masakatsu Yanagimachi, Masahide Yamamoto, Tetsuya Fukuda, Osamu Miura, Ryutaro Oba, Akira Igarashi, Kinya Nagata, Tomohiro Morio: Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD. Int J Hematol. 2021.06; 113 (6): 910-920. ( PubMed , DOI )

  26. Kaori Uchino, Lam Vu Quang, Shohei Mizuno, Tomohiro Horio, Hidesuke Yamamoto, Ichiro Hanamura, Yoshihisa Kodera, J Luis Espinoza, Makoto Onizuka, Koichi Kashiwase, Yasuo Morishima, Takahiro Fukuda, Noriko Doki, Koichi Miyamura, Takehiko Mori, Eriko Morishita, Shinji Nakao, Akiyoshi Takami: Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation. Genes Immun. 2021.05; 22 (1): 35-43. ( PubMed , DOI )

  27. Kurosawa S, Kaito S, Uchida N, Fukuda T, Doki N, Mori T, Hasegawa Y, Takada S, Sakaida E, Tanaka M, Ikegame K, Kanda J, Atsuta Y, Kako S: Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia with high hyperdiploidy: a retrospective nationwide study. Leukemia & lymphoma. 2021.05; 62 (10): 1-7. ( PubMed , DOI )

  28. Motohito Okabe, Takaaki Konuma, Maki Oiwa-Monna, Seiko Kato, Masamichi Isobe, Satoshi Takahashi, Arinobu Tojo: Impact of a prior history of cancer on prognosis after myeloablative single-unit cord blood transplantation. Jpn J Clin Oncol. 2021.04; 51 (4): 657-660. ( PubMed , DOI )

  29. Takaaki Konuma, Maki Monna-Oiwa, Yuta Kaito, Masamichi Isobe, Motohito Okabe, Seiko Kato, Satoshi Takahashi, Arinobu Tojo: Early-Phase Peripheral Blood Eosinophilia Predicts Lower Overall and Non-Relapse Mortality After Single-Unit Cord Blood Transplantation. Transplant Cell Ther. 2021.04; 27 (4): 336.e1-336.e9. ( PubMed , DOI )

  30. Yuki Fukawa, Kei Sakamoto, Takuma Kugimoto, Yasuyuki Michi, Hiroyuki Harada, Masahide Yamamoto, Masanobu Kitagawa, Tohru Ikeda, Kouhei Yamamoto: Nodular lymphocyte-predominant Hodgkin lymphoma involving the hard palate. Pathol Int. 2021.03; 71 (3): 213-215. ( PubMed , DOI )

  31. Karigane D, Kasahara H, Shiroshita K, Fujita S, Kobayashi H, Tamaki S, Yamazaki R, Yahagi K, Yatabe Y, Kondoh N, Arai T, Katagiri H, Shimizu N, Sakurai M, Kikuchi T, Kato J, Shimizu T, Hayakawa T, Yaguchi T, Matsushita M, Nakajima H, Kawakami Y, Murata M, Mori T, Sasaki T, Okamoto S, Takubo K: Detection of residual disease in chronic myeloid leukemia utilizing genomic next generation sequencing reveals persistence of differentiated Ph+ B cells but not bone marrow stem/progenitors. Leukemia & lymphoma. 2021.03; 62 (3): 679-687. ( PubMed , DOI )

  32. Fujimoto A, Anzai T, Fukuda T, Uchida N, Ohta T, Mori T, Sawa M, Yoshioka S, Miyamoto T, Uchiyama H, Katayama Y, Matsuoka KI, Shiratori S, Nakazawa H, Kanda J, Ichinohe T, Atsuta Y, Fujita N, Kondo E, Suzuki R: Impact of event-free survival status after stem cell transplantation on subsequent survival of patients with lymphoma. Blood advances. 2021.03; 5 (5): 1412-1424. ( PubMed , DOI )

  33. Morishima S, Fukuda T, Doki N, Mori T, Onizuka M, Kawakita T, Kato C, Ozawa Y, Tanaka M, Kurokawa M, Kamimura T, Inoue M, Tanaka J, Ichinohe T, Atsuta Y, Morishima Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors. Bone marrow transplantation. 2021.03; 56 (3): 646-654. ( PubMed , DOI )

  34. Takanobu Morishita, Rena Matsumoto, Tomoki Naito, Yosuke Domon, Kenichiro Takeda, Kohei Ishigiwa, Tomoe Ichiki, Motohito Okabe, Motoki Eguchi, Yuka Kawaguchi, Marie Ohbiki, Tatsunori Goto, Yukiyasu Ozawa, Koichi Miyamura: Pretransplant increasing rate of lactate dehydrogenase as a predictor of transplant outcomes for patients with myeloid hematological malignancies. Bone Marrow Transplant. 2021.03; 56 (7): 1732-1736. ( PubMed , DOI )

  35. Izumi Y, Kanayama M, Shen Z, Kai M, Kawamura S, Akiyama M, Yamamoto M, Nagao T, Okada K, Kawamata N, Toyota S, Ohteki T: An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy. Frontiers in immunology. 2021.02; 12 618081. ( PubMed , DOI )

  36. Morikawa S, Tsunoda K, Miyashita Y, Nasu M, Horie N, Usuda S, Kato J, Mori T, Nakagawa T: Management of generalized severe periodontitis using full-mouth disinfection and systemic antibiotics in a leukemic patient before stem cell transplantation: A case report. Clinical case reports. 2021.02; 9 (2): 644-649. ( PubMed , DOI )

  37. Ueda N, Konuma T, Aoki J, Takahashi S, Ozawa Y, Mori T, Ota S, Eto T, Takada S, Yoshioka S, Shiratori S, Kako S, Onizuka M, Fukuda T, Kanda Y, Atsuta Y, Yanada M: Prognostic Impact of the Fractionation of Total Body Irradiation for Patients with Acute Myeloid Leukemia Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation. Transplantation and cellular therapy. 2021.02; 27 (2): 185.e1-185.e6. ( PubMed , DOI )

  38. Nakayama H, Yamazaki R, Kato J, Koda Y, Sakurai M, Mori T: Impact of Specific Antibody Level on Human Herpesvirus 6 Reactivation after Allogeneic Stem Cell Transplantation. Transplantation and cellular therapy. 2021.02; 27 (2): 174.e1-174.e5. ( PubMed , DOI )

  39. Maryam Aftabizadeh, Yi-Jia Li, Qianqian Zhao, Chunyan Zhang, Nigus Ambaye, Jieun Song, Toshikage Nagao, Christoph Lahtz, Marwan Fakih, David K Ann, Hua Yu, Andreas Herrmann: Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis. JCI Insight. 2021.01; 6 (2): ( PubMed , DOI )

  40. Onishi Y, Mori T, Yamazaki H, Takenaka K, Yamaguchi H, Shingai N, Ozawa Y, Iida H, Ota S, Uchida N, Miyamoto T, Katayama Y, Kato J, Yoshioka S, Onizuka M, Ichinohe T, Atsuta Y, Adult Aplastic Anemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia. Annals of hematology. 2021.01; 100 (1): 217-228. ( PubMed , DOI )

  41. Nakamura Y, Takenaka K, Yamazaki H, Onishi Y, Ozawa Y, Ikegame K, Matsuoka KI, Toubai T, Ueda Y, Kanda Y, Ichinohe T, Atsuta Y, Mori T: Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria. International journal of hematology. 2021.01; 113 (1): 122-127. ( PubMed , DOI )

  42. Takenaka K, Onishi Y, Mori T, Hirakawa T, Tada Y, Uchida N, Kobayashi T, Kanda Y, Ozawa Y, Ota S, Iida H, Fukushima K, Kimua T, Fukuda T, Atsuta Y, Matsuto K, Yamazaki H, Nakasone H: Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation. Transplantation and cellular therapy. 2021.01; 27 (1): 82.e1-82.e8. ( PubMed , DOI )

  43. Kikuchi T, Mori T, Ohwada C, Onoda M, Shimizu H, Yokoyama H, Onizuka M, Koda Y, Kato J, Takeda Y, Hino Y, Mishina T, Sakaida E, Shono K, Nagao Y, Yokota A, Matsumoto K, Morita K, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT).: Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine. International journal of hematology. 2021.01; 113 (1): 128-133. ( PubMed , DOI )

  44. Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Miyazaki T, Aotsuka N, Gotoh M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT).: Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter Analysis. Transplantation and cellular therapy. 2021.01; 27 (1): 70.e1-70.e8. ( PubMed , DOI )

  45. Kuboki Mai, Umezawa Yoshihiro, Motomura Yotaro, Okada Keigo, Nogami Ayako, Nagao Toshikage, Miura Osamu, Yamamoto Masahide: Severe Motor Weakness Due to Disturbance in Peripheral Nerves Following Tisagenlecleucel Treatment IN VIVO. 2021; 35 (6): 3407-3411. ( PubMed , DOI )

  46. Yuriko Sorimachi, Daiki Karigane, Yukako Ootomo, Hiroshi Kobayashi, Takayuki Morikawa, Kinya Otsu, Yoshiaki Kubota, Shinichiro Okamoto, Nobuhito Goda, Keiyo Takubo: p38α plays differential roles in hematopoietic stem cell activity dependent on aging contexts. Journal of Biological Chemistry. 2021; 296 100563. ( PubMed , DOI )

  1. Konuma T, Ishiyama K, Igarashi A, Uchida N, Ozawa Y, Fukuda T, Ueda Y, Matsuoka KI, Mori T, Katayama Y, Onizuka M, Ichinohe T, Atsuta Y, Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020.12; 26 (24): 6483-6493. ( PubMed , DOI )

  2. Abe R, Mori T, Tanigawa T, Koda Y, Hosoe N, Sakurai M, Kikuchi T, Kato J, Shimizu T, Ogata H, Kanai T, Sasaki A, Kameyama K, Okamoto S: Clinical characteristics and outcomes of duodenal-type follicular lymphoma. Leukemia & lymphoma. 2020.12; 61 (13): 3266-3268. ( PubMed , DOI )

  3. Takehiko Mori, Masuho Saburi, Maki Hagihara, Masaaki Mori, Rie Yamazaki, Jun Kato: Long-term remission of cryopyrin-associated periodic syndrome after allogeneic haematopoietic stem cell transplantation. Ann Rheum Dis. 2020.11; ( PubMed , DOI )

  4. Fujita H, Sasaki T, Miyamoto T, Akutsu SN, Sato S, Mori T, Nakabayashi K, Hata K, Suzuki H, Kosaki K, Matsuura S, Matsubara Y, Amagai M, Kubo A: Premature aging syndrome showing random chromosome number instabilities with CDC20 mutation. Aging cell. 2020.11; 19 (11): e13251. ( PubMed , DOI )

  5. Takaaki Konuma, Susumu Tanoue, Mai Mizusawa, Motohito Okabe, Masamichi Isobe, Seiko Kato, Satoshi Takahashi, Arinobu Tojo: Tuberculous pleurisy in an adult patient after cord blood transplantation. EJHaem. 2020.11; 1 (2): 424-425. ( PubMed , DOI )

  6. Mori T, Mikita K, Koda Y, Sakurai M, Saburi M, Hasegawa N, Kato J: Seroprevalence of Toxoplasma gondii among Japanese adults with hematological diseases. International journal of hematology. 2020.11; 112 (5): 755-756. ( PubMed , DOI )

  7. Takaaki Konuma, Chisato Kohara, Eri Watanabe, Shunsuke Takahashi, Genki Ozawa, Kentaro Inomata, Kei Suzuki, Motoko Mizukami, Etsuko Nagai, Motohito Okabe, Masamichi Isobe, Seiko Kato, Maki Oiwa-Monna, Satoshi Takahashi, Arinobu Tojo: Impact of Intestinal Microbiota on Reconstitution of Circulating Monocyte, Dendritic Cell, and Natural Killer Cell Subsets in Adults Undergoing Single-Unit Cord Blood Transplantation. Biol Blood Marrow Transplant. 2020.11; 26 (11): e292-e297. ( PubMed , DOI )

  8. Kota Yoshifuji, Kyoko Inamoto, Yuko Kiridoshi, Kozue Takeshita, Satoshi Sasajima, Yukiko Shiraishi, Yuko Yamashita, Yuko Nisaka, Yukari Ogura, Rie Takeuchi, Takashi Toya, Aiko Igarashi, Yuho Najima, Noriko Doki, Takeshi Kobayashi, Kazuteru Ohashi, Wataru Suda, Koji Atarashi, Atsushi Shiota, Masahira Hattori, Kenya Honda, Kazuhiko Kakihana: Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation. Blood Adv. 2020.10; 4 (19): 4607-4617. ( PubMed , DOI )

  9. Towako Taguchi, Morito Kurata, Iichiroh Onishi, Yuko Kinowako, Yunosuke Sato, Sayuri Shiono, Sachiko Ishibashi, Masumi Ikeda, Masahide Yamamoto, Masanobu Kitagawa, Kouhei Yamamoto: SECISBP2 is a novel prognostic predictor that regulates selenoproteins in diffuse large B-cell lymphoma. Lab Invest. 2020.10; ( PubMed , DOI )

  10. Yanada M, Fukuda T, Tanaka M, Ota S, Toya T, Mori T, Uchida N, Ozawa Y, Nakamae H, Kanda Y, Ichinohe T, Atsuta Y, Yano S: Long-term results of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia: a retrospective analysis of 10-year follow-up data. Bone marrow transplantation. 2020.10; 55 (10): 2008-2016. ( PubMed , DOI )

  11. 田畑 真梨子, 佐藤 悠佑, 木暮 泰寛, McClure Marni B., 斎藤 優樹, 新垣 清登, 吉藤 康太, 古屋 淳史, 河野 隆志, 白石 友一, 久米 春喜, 片岡 圭亮: がん分子標的治療薬・がん免疫治療薬への抵抗性に関わる分子機構とその克服　遺伝性淡明細胞型腎細胞癌における腫瘍内または腫瘍間の遺伝的、免疫的不均一性 日本癌学会総会記事. 2020.10; 79回 S4-3. ( ichushi )

  12. 古屋 淳史, 斎藤 優樹, 亀田 拓郎, 木暮 泰寛, McClure Marni B., 新垣 清登, 吉藤 康太, 田畑 真梨子, 下田 和哉, 片岡 圭亮: がんの一細胞生物学　マルチオミクス単一細胞解析によるHTLV-1感染状態およびATLにおける細胞動態の網羅的解明 日本癌学会総会記事. 2020.10; 79回 S12-3. ( ichushi )

  13. Mori T, Shiratori S, Suzumiya J, Kurokawa M, Shindo M, Naoyuki U, Katsuto T, Miyamoto T, Morishige S, Hirokawa M, Fukuda T, Atsuta Y, Suzuki R: Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome. Hematological oncology. 2020.08; 38 (3): 266-271. ( PubMed , DOI )

  14. Motohito Okabe, Takanobu Morishita, Tomoe Ichiki, Yuka Kawaguchi, Yoonha Lee, Marie Ohbiki, Miyo Goto, Masahide Osaki, Hiroaki Araie, Tatsunori Goto, Yukiyasu Ozawa, Koichi Miyamura: The stability of initial tacrolimus concentration following allogeneic hematopoietic stem cell transplantation reduces the risk of acute GVHD. Clin Transplant. 2020.08; 34 (10): e14052. ( PubMed , DOI )

  15. Ichiro Yonese, Chizuko Sakashita, Ken-Ichi Imadome, Tohru Kobayashi, Masahide Yamamoto, Akihisa Sawada, Yoshinori Ito, Noriko Fukuhara, Asao Hirose, Yusuke Takeda, Masanori Makita, Tomoyuki Endo, Shun-Ichi Kimura, Masataka Ishimura, Osamu Miura, Shouichi Ohga, Hiroshi Kimura, Shigeyoshi Fujiwara, Ayako Arai: Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv. 2020.07; 4 (13): 2918-2926. ( PubMed , DOI )

  16. Sakurai M, Mori T, Uchiyama H, Ago H, Iwato K, Eto T, Iwasaki H, Kawata T, Takamatsu H, Yamasaki S, Takanashi M, Ichinohe T, Atsuta Y, Suzuki R: Outcome of stem cell transplantation for Waldenström's macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group. Annals of hematology. 2020.07; 99 (7): 1635-1642. ( PubMed , DOI )

  17. Kikuchi T, Kato J, Koda Y, Sakurai M, Hayashi Y, Mori T: Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF-producing multiple myeloma. Annals of hematology. 2020.07; 99 (7): 1667-1668. ( PubMed , DOI )

  18. Tachibana T, Ishizaki T, Takahashi S, Najima Y, Kimura SI, Sakaida E, Onizuka M, Mori T, Fujisawa S, Fujiwara SI, Saito T, Hagihara M, Aotsuka N, Gotoh M, Usuki K, Tsukada N, Kanda J, Kanamori H, Kanda Y, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT).: Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis. Bone marrow transplantation. 2020.07; 55 (7): 1497-1501. ( PubMed , DOI )

  19. Yuki Saito, Junji Koya, Mitsugu Araki, Yasunori Kogure, Sumito Shingaki, Mariko Tabata, Marni B McClure, Kota Yoshifuji, Shigeyuki Matsumoto, Yuta Isaka, Hiroko Tanaka, Takanori Kanai, Satoru Miyano, Yuichi Shiraishi, Yasushi Okuno, Keisuke Kataoka: Landscape and function of multiple mutations within individual oncogenes. Nature. 2020.06; 582 (7810): 95-99. ( PubMed , DOI )

  20. Toyama T, Mori T, Kato J, Sugita K, Hasegawa N, Nakata N, Hoshino Y, Okamoto S: Disseminated Mycobacterium massiliense infection in a patient with myelodysplastic syndrome undergoing allogeneic bone marrow transplantation. Transplant infectious disease : an official journal of the Transplantation Society. 2020.06; 22 (3): e13278. ( PubMed , DOI )

  21. Kato M, Nakasone H, Nakano N, Fuji S, Shinohara A, Yokoyama H, Sakashita K, Hori T, Takahashi S, Nara M, Kanda Y, Mori T, Takita J, Kawaguchi H, Kawakita T, Ichinohe T, Fukuda T, Atsuta Y, Ogata M, Transplantation Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation. 2020.06; 55 (6): 1023-1028. ( PubMed , DOI )

  22. Kurosawa S, Mori A, Tsukagoshi M, Onishi Y, Ohwada C, Mori T, Goto H, Asano-Mori Y, Nawa Y, Hino M, Fukuchi T, Mori Y, Yamahana R, Inamoto Y, Fukuda T: Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in Japan. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020.05; 26 (5): 949-955. ( PubMed , DOI )

  23. Kawamura K, Kanda J, Ohashi K, Fukuda T, Iwato K, Eto T, Fujiwara SI, Mori T, Fukushima K, Ozawa Y, Uchida N, Ashida T, Ichinohe T, Atsuta Y, Kanda Y: Influence of HLA 1-3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation. Annals of hematology. 2020.05; 99 (5): 1099-1110. ( PubMed , DOI )

  24. Sakurai M, Takemoto H, Mori T, Okamoto S, Yamazaki S: In vivo expansion of functional human hematopoietic stem progenitor cells by butyzamide. International journal of hematology. 2020.05; 111 (5): 739-741. ( PubMed , DOI )

  25. Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Matsumoto K, Aotsuka N, Gotoh M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT).: Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter Analysis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020.05; 26 (5): 998-1004. ( PubMed , DOI )

  26. Ikeda K, Ohto H, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Muroi K, Mori T, Kasama K, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Kanda J, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Minakawa K, Tanosaki R: Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study. Transfusion. 2020.05; 60 (5): 1015-1023. ( PubMed , DOI )

  27. Correa MEP, Cheng KKF, Chiang K, Kandwal A, Loprinzi CL, Mori T, Potting C, Rouleau T, Toro JJ, Ranna V, Vaddi A, Peterson DE, Bossi P, Lalla RV, Elad S: Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2020.05; 28 (5): 2449-2456. ( PubMed , DOI )

  28. Uekusa T, Sato R, Yoo D, Kawamoto T, Mori T: Transistor Characteristics of Charge-Transfer Complexes Observed across a Neutral-Ionic Transition. ACS applied materials & interfaces. 2020.05; 12 (21): 24174-24183. ( PubMed , DOI )

  29. Shiroshita K, Mori T, Kato J, Sakurai M, Koda Y, Abe R, Murakami K, Sumiya C, Fujita S, Yamaguchi K, Yamazaki R, Nakayama H, Suzuki S, Nakahara J, Okamoto S: Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention. Bone marrow transplantation. 2020.05; 55 (5): 939-945. ( PubMed , DOI )

  30. Mori T, Kikuchi T, Kato J, Koda Y, Sakurai M, Kikumi O, Inose R, Murata M, Hasegawa N, Nakayama H, Yamazaki R, Okamoto S: Seasonal changes in indoor airborne fungal concentration in a hematology ward. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2020.04; 26 (4): 363-366. ( PubMed , DOI )

  31. Shunya Matsumoto, Toshiki Kijima, Yoh Matsuoka, Masahide Yamamoto, Yasuhisa Fujii: A case of recurrent thrombocytopenia involving divergent immune-related mechanisms associated with pembrolizumab. Eur. J. Cancer. 2020.03; ( PubMed , DOI )

  32. Kako S, Yamazaki H, Ohashi K, Ozawa Y, Ota S, Kanda Y, Maeda T, Kato J, Ishiyama K, Matsuoka KI, Miyamoto T, Iida H, Ikegame K, Fukuda T, Ichinohe T, Atsuta Y, Mori T, Adult Aplastic Anemia Working Group of the Japanese Society for Hematopoietic Cell Transplantation.: Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020.03; 26 (3): 445-450. ( PubMed , DOI )

  33. Kako S, Kanda Y, Onizuka M, Aotsuka N, Usuki K, Tachibana T, Kobayashi T, Kato J, Yano S, Shimizu H, Shono K, Tanaka M, Tsukamoto S, Mori T, Yamazaki E, Najima Y, Hangaishi A, Hoshino T, Watanabe R, Matsumoto K, Okamoto S, for Kanto Study Group for Cell Therapy (KSGCT).: Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study. American journal of hematology. 2020.03; 95 (3): 251-257. ( PubMed , DOI )

  34. Iida M, Nakasone H, Yamashita T, Inoue M, Ishida Y, Uchiyama H, Katayama Y, Miyamoto T, Yoshioka S, Shiratori S, Mori T, Sawa M, Sugio Y, Fukuda T, Ichinohe T, Atsuta Y, Inamoto Y, Late Effect and Quality of Life Working Group of the Japan Society for Hematopoietic Cell Transplantation: Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation. Blood cell therapy. 2020.02; 3 (1): 11-17. ( PubMed , DOI )

  35. Koji Nishikawa, Kiminori Kimura, Yoshinobu Kanda, Masaya Sugiyama, Kazuhiko Kakihana, Noriko Doki, Kazuteru Ohashi, Sung Kwan Bae, Kazuhiro Takahashi, Yuko Ishihara, Ishikazu Mizuno, Yasushi Onishi, Masahiro Onozawa, Makoto Onizuka, Masahide Yamamoto, Tetsuya Ishikawa, Kazuaki Inoue, Shigeru Kusumoto, Satoshi Hashino, Hidetsugu Saito, Tatsuya Kanto, Hisashi Sakamaki, Masashi Mizokami: A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation. Bone Marrow Transplant.. 2020.02; ( PubMed , DOI )

  36. Akiyama, H; Umezawa, Y; Watanabe, D; Okada, K; Ishida, S; Nogami, A; Miura, O: Inhibition of USP9X Downregulates JAK2-V617F and Induces Apoptosis Synergistically with BH3 Mimetics Preferentially in Ruxolitinib-Persistent JAK2-V617F-Positive Leukemic Cells CANCERS. 2020.02; 12 (2): ( PubMed , DOI )

  37. Horio T, Morishita E, Mizuno S, Uchino K, Hanamura I, Espinoza JL, Morishima Y, Kodera Y, Onizuka M, Kashiwase K, Fukuda T, Doki N, Miyamura K, Mori T, Nakao S, Takami A: Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients. Cancers. 2020.02; 12 (2): ( PubMed , DOI )

  38. Ohwada C, Sakaida E, Igarashi A, Kobayashi T, Doki N, Mori T, Kato J, Koda Y, Kanamori H, Tanaka M, Tachibana T, Fujisawa S, Nakajima Y, Numata A, Toyosaki M, Aoyama Y, Onizuka M, Hagihara M, Koyama S, Kanda Y, Nakasone H, Shimizu H, Kato S, Watanabe R, Shono K, Sakai R, Saito T, Nakaseko C, Okamoto S: A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020.01; 26 (1): 162-170. ( PubMed , DOI )

  39. Murata M, Suzuki R, Nishida T, Shirane S, Shimazu Y, Minami Y, Mori T, Doki N, Kanda Y, Uchida N, Tanaka M, Ishikawa J, Togitani K, Fukuda T, Ichinohe T, Atsuta Y, Nagamura-Inoue T, Kiyoi H: Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis. Internal medicine (Tokyo, Japan). 2020; 59 (16): 1947-1956. ( PubMed , DOI )

  1. Kawase T, Tanaka H, Kojima H, Uchida N, Ohashi K, Fukuda T, Ozawa Y, Ikegame K, Eto T, Mori T, Miyamoto T, Hidaka M, Shiratori S, Takanashi M, Atsuta Y, Ichinohe T, Kanda Y, Kanda J, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019.12; 25 (12): 2482-2489. ( PubMed , DOI )

  2. Shimizu H, Doki N, Kanamori H, Sakura T, Mori T, Machida S, Takahashi S, Ohwada C, Fujisawa S, Yano S, Hagihara M, Kanda Y, Onoda M, Gotoh M, Kako S, Taguchi J, Usuki K, Kawai N, Aotsuka N, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT).: Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant. Bone marrow transplantation. 2019.12; 54 (12): 2020-2026. ( PubMed , DOI )

  3. Watanabe D, Nogami A, Okada K, Akiyama H, Umezawa Y, Miura O: FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM. Cancers. 2019.11; 11 (12): ( PubMed , DOI )

  4. Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Matsumoto K, Aotsuka N, Goto M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S, Kanto Study., Group for Cell Therapy (KSGCT).: Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis. Leukemia. 2019.11; 33 (11): 2610-2618. ( PubMed , DOI )

  5. Toshinobu Nishimura, Haojun Xu, Masayuki Iwasaki, Daiki Karigane, Brandon Saavedra, Yusuke Takahashi, Fabian P Suchy, Shinichiro Monobe, Renata M Martin, Manami Ohtaka, Mahito Nakanishi, Scott R Burrows, Michael L Cleary, Ravindra Majeti, Akira Shibuya, Hiromitsu Nakauchi: Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells. Gene Therapy. 2019.11; 27 (10-11): 525-534. ( PubMed , DOI )

  6. Arai Y, Kondo T, Fuse K, Shibasaki Y, Masuko M, Sugita J, Teshima T, Uchida N, Fukuda T, Kakihana K, Ozawa Y, Eto T, Tanaka M, Ikegame K, Mori T, Iwato K, Ichinohe T, Kanda Y, Atsuta Y: Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation. Blood advances. 2019.11; 3 (22): 3626-3634. ( PubMed , DOI )

  7. Endo Y, Oshima G, Hibi T, Shinoda M, Sakurai M, Koda Y, Izawa Y, Obara H, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Fukushima A, Yokose T, Mori T, Kuroda T, Kitagawa Y: Achievement of Durable and Complete Remission of Graft-versus-host Disease After Liver Transplantation With Ruxolitinib: A Case Report. Transplantation. 2019.11; 103 (11): e375-e377. ( PubMed , DOI )

  8. Araie Hiroaki, Kawaguchi Yuka, Okabe Motohito, Lee Yoonha, Ohbiki Marie, Osaki Masahide, Goto Miyo, Goto Tatsunori, Morishita Takanobu, Ozawa Yukiyasu, Miyamura Koichi: 骨髄性悪性腫瘍における同種造血幹細胞移植前のcontrolling nutritional status(CONUT)による臨床成績の予測(Prediction of clinical outcome by controlling nutritional status(CONUT) before allogeneic hematopoietic stem cell transplantation in myeloid malignancies) International Journal of Hematology. 2019.11; 110 (5): 599-605. ( ichushi )

  9. Hiroaki Araie, Yuka Kawaguchi, Motohito Okabe, Yoonha Lee, Marie Ohbiki, Masahide Osaki, Miyo Goto, Tatsunori Goto, Takanobu Morishita, Yukiyasu Ozawa, Koichi Miyamura: Prediction of clinical outcome by controlling nutritional status (CONUT) before allogeneic hematopoietic stem cell transplantation in myeloid malignancies. Int J Hematol. 2019.11; 110 (5): 599-605. ( PubMed , DOI )

  10. Takashi Ikeda, Keita Mori, Koji Kawamura, Takehiko Mori, Shotaro Hagiwara, Yasunori Ueda, Kaoru Kahata, Naoyuki Uchida, Nobuhiro Tsukada, Satoshi Murakami, Masahide Yamamoto, Tsutomu Takahashi, Tatsuo Ichinohe, Makoto Onizuka, Yoshiko Atsuta, Yoshinobu Kanda, Shinichiro Okamoto, Kazutaka Sunami, Hiroyuki Takamatsu: Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation. Hematol Oncol. 2019.10; ( PubMed , DOI )

  11. Mizuno S, Kawamura K, Hanamura I, Sunami K, Mori T, Nakamura F, Iida S, Nakazawa H, Makita M, Kako S, Sawa M, Ueda Y, Takahashi H, Kanda Y, Ichinohe T, Atsuta Y, Takamatsu H, Takami A: Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents. Bone marrow transplantation. 2019.10; 54 (10): 1595-1604. ( PubMed , DOI )

  12. Masuda K, Nakazato T, Nishiyama-Fujita Y, Ito C, Ogura S, Mizuno K, Kamiya T, Aisa Y, Mori T: Successful treatment with ponatinib for central nervous system relapse of Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia. Internal medicine journal. 2019.10; 49 (10): 1332-1334. ( PubMed , DOI )

  13. Kimura F, Kanda J, Ishiyama K, Yabe T, Yoshifuji K, Fukuda T, Ozawa Y, Iwato K, Eto T, Mori T, Uchida N, Ota S, Sakura T, Ichinohe T, Atsuta Y, Kanda Y, donor/source working group of the Japan Society for Hematopoietic Cell Transplantation.: ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation. Bone marrow transplantation. 2019.10; 54 (10): 1676-1685. ( PubMed , DOI )

  14. Tokuhira M, Saito S, Suzuki K, Higashi M, Momose S, Shimizu T, Mori T, Kimura Y, Amano K, Okamoto S, Takeuchi T, Tamaru JI, Kizaki M: Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders. Leukemia & lymphoma. 2019.10; 60 (10): 2508-2515. ( PubMed , DOI )

  15. Masahide Yamamoto, Keisuke Tanaka, Yoshihiro Umezawa, Toshikage Nagao, Shigeo Toyota, Osamu Miura: Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management Strategy. Anticancer Res.. 2019.09; 39 (9): 5115-5122. ( PubMed , DOI )

  16. Kouhei Yamamoto, Shinya Abe, Ayaka Honda, Jun Hashimoto, Yuuki Aizawa, Sachiko Ishibashi, Taro Takemura, Nobutaka Hanagata, Masahide Yamamoto, Osamu Miura, Morito Kurata, Masanobu Kitagawa: Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma. Lab. Invest.. 2019.09; ( PubMed , DOI )

  17. Kota Yoshifuji, Yoshihiro Umezawa, Ayako Ichikawa, Ken Watanabe, Osamu Miura, Masahide Yamamoto: Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic Cases. In Vivo. 2019.09; 33 (5): 1599-1604. ( PubMed , DOI )

  18. Kato K, Mori T, Kim SW, Sawa M, Sakai T, Hashimoto H, Taguchi J, Oyake T, Kurahashi S, Imada K, Ohno H, Tanaka J, Ichinohe T, Atsuta Y, Suzuki R, Suzumiya J: Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation. Bone marrow transplantation. 2019.09; 54 (9): 1515-1517. ( PubMed , DOI )

  19. Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y: Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019.09; 25 (9): 1851-1858. ( PubMed , DOI )

  20. Nishiyama-Fujita Y, Nakazato T, Ito C, Ogura S, Mizuno K, Kamiya T, Aisa Y, Mori T: Rare case of ocular adnexal relapse with mantle cell lymphoma treated with ibrutinib monotherapy. Internal medicine journal. 2019.09; 49 (9): 1187-1189. ( PubMed , DOI )

  21. Kato H, Kato K, Kim SW, Fukuda T, Mori T, Sawa M, Ohno Y, Yoshioka S, Iwato Y, Taji H, Onizuka M, Kurahashi S, Ichinohe T, Suzumiya J, Suzuki R: Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation: on behalf of the Adult Lymphoma Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT). British journal of haematology. 2019.09; 186 (6): e170-e175. ( PubMed , DOI )

  22. Nakayama H, Yamazaki R, Kato J, Koda Y, Sakurai M, Abe R, Watanuki S, Sumiya C, Shiroshita K, Fujita S, Yamaguchi K, Okamoto S, Mori T: Human Herpesvirus 6 Reactivation Evaluated by Digital Polymerase Chain Reaction and Its Association With Dynamics of CD134-Positive T Cells After Allogeneic Hematopoietic Stem Cell Transplantation. The Journal of infectious diseases. 2019.08; 220 (6): 1001-1007. ( PubMed , DOI )

  23. Kikuchi T, Arai M, Koda Y, Kato J, Shimizu T, Katano H, Fujii-Nishimura Y, Sakamoto M, Ebinuma H, Nakamoto N, Kanai T, Okamoto S, Mori T: Late-onset visceral varicella-zoster virus infection presented as acute liver failure after allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society. 2019.08; 21 (4): e13121. ( PubMed , DOI )

  24. Herrmann A, Nagao T, Zhang C, Lahtz C, Li YJ, Yue C, Mülfarth R, Yu H: An effective cell-penetrating antibody delivery platform. JCI insight. 2019.07; 4 (14): ( PubMed , DOI )

  25. Kota Yoshifuji, Takashi Toya, Hiroto Adachi, Masahiro Fujita, Atsushi Wada, Ryosuke Konuma, Yuya Kishida, Tatsuya Konishi, Akihito Nagata, Yuta Yamada, Satoshi Kaito, Takuma Kumagai, Kyoko Inamoto, Megumi Akiyama, Aiko Igarashi, Yuho Najima, Noriko Doki, Takeshi Kobayashi, Kazuhiko Kakihana, Hisashi Sakamaki, Kazuteru Ohashi: Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide. Int J Hematol. 2019.07; 110 (1): 115-118. ( PubMed , DOI )

  26. Shimizu R, Takeuchi M, Sakaida E, Ohwada C, Toyosaki M, Machida S, Onizuka M, Shono K, Onoda M, Saito T, Yano S, Tanaka M, Fujisawa S, Mori T, Usuki K, Takahashi S, Kanamori H, Nakaseko C, Okamoto S: Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation. Annals of hematology. 2019.07; 98 (7): 1781-1783. ( PubMed , DOI )

  27. Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Shiratori S, Miyakoshi S, Ishiyama K, Ikegame K, Matsuhashi Y, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R: Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019.07; 25 (7): 1441-1449. ( PubMed , DOI )

  28. Mizuno K, Nakazato T, Ito C, Fujita Y, Ogura S, Kamiya T, Sakurai A, Aisa Y, Mori T: The prognostic value of geriatric nutritional risk index in patients with follicular lymphoma. Annals of hematology. 2019.07; 98 (7): 1777-1779. ( PubMed , DOI )

  29. Yamazaki R, Kato J, Koda Y, Sakurai M, Tozawa K, Okayama M, Nakayama H, Watanuki S, Kikuchi T, Hasegawa N, Okamoto S, Mori T: Impact of immunoglobulin G2 subclass level on late-onset bacterial infection after allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society. 2019.06; 21 (3): e13086. ( PubMed , DOI )

  30. Mori T, Onishi Y, Ozawa Y, Kato C, Kai T, Kanda Y, Kurokawa M, Tanaka M, Ashida T, Sawayama Y, Fukuda T, Ichinohe T, Atsuta Y, Yamazaki H: Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with hepatitis-associated aplastic anemia. International journal of hematology. 2019.06; 109 (6): 711-717. ( PubMed , DOI )

  31. Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, Mori T, Sawa M, Ichinohe T, Atsuta Y, Kanda J, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT. International journal of hematology. 2019.06; 109 (6): 684-693. ( PubMed , DOI )

  32. Ishikawa A, Otaka Y, Kamisako M, Suzuki T, Miyata C, Tsuji T, Matsumoto H, Kato J, Mori T, Okamoto S, Liu M: Factors affecting lower limb muscle strength and cardiopulmonary fitness after allogeneic hematopoietic stem cell transplantation. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2019.05; 27 (5): 1793-1800. ( PubMed , DOI )

  33. Tanigawa T, Abe R, Kato J, Hosoe N, Ogata H, Kameyama K, Okamoto S, Mori T: Histological transformation in duodenal-type follicular lymphoma: a case report and review of the literature. Oncotarget. 2019.05; 10 (36): 3424-3429. ( PubMed )

  34. Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Fujisawa S, Onishi Y, Yano S, Onizuka M, Kanda Y, Mizuno I, Taniguchi S, Yamashita T, Inamoto Y, Okamoto S, Atsuta Y: Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey. Bone marrow transplantation. 2019.04; 54 (4): 611-615. ( PubMed , DOI )

  35. Yanada M, Masuko M, Mori J, Aoki J, Mizuno S, Fukuda T, Kakihana K, Ozawa Y, Ota S, Kanamori H, Mori T, Nakamae H, Eto T, Shiratori S, Maeda T, Iwato K, Ichinohe T, Kanda Y, Tanaka J, Atsuta Y, Yano S: Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades. Bone marrow transplantation. 2019.04; 54 (4): 578-586. ( PubMed , DOI )

  36. Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y: Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature. World journal of gastroenterology. 2019.04; 25 (15): 1899-1906. ( PubMed , DOI )

  37. Sakurai Masatoshi, Kikuchi Taku, Karigane Daiki, Kasahara Hidenori, Matsuki Eri, Hashida Risa, Yamane Yusuke, Abe Ryohei, Koda Yuya, Toyama Takaaki, Kato Jun, Shimizu Takayuki, Yokoyama Yuta, Suzuki Sayo, Nakamura Tomonori, Okamoto Shinichiro, Mori Takehiko: 慢性骨髄性白血病患者の長期イマチニブ療法と関連する腎機能障害と貧血(Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia) International Journal of Hematology. 2019.03; 109 (3): 292-298. ( ichushi )

  38. Sakurai M, Kikuchi T, Karigane D, Kasahara H, Matsuki E, Hashida R, Yamane Y, Abe R, Koda Y, Toyama T, Kato J, Shimizu T, Yokoyama Y, Suzuki S, Nakamura T, Okamoto S, Mori T: Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia. International journal of hematology. 2019.03; 109 (3): 292-298. ( PubMed , DOI )

  39. Nogami Ayako, Okada Keigo, Ishida Shinya, Akiyama Hiroki, Umezawa Yoshihiro, Miura Osamu: Inhibition of the STAT5/Pim Kinase Axis Enhanecs Cytotoxic Effects of Proteasome Inhibitors on FLT3-ITD-Positive Cells by Cooperatively Inhibiting the mTORC1/4EBP1/S6K/Mcl-1 Pathway TRANSLATIONAL ONCOLOGY. 2019.02; 12 (2): 336-349. ( PubMed , DOI )

  40. Miyamura K, Yamashita T, Atsuta Y, Ichinohe T, Kato K, Uchida N, Fukuda T, Ohashi K, Ogawa H, Eto T, Inoue M, Takahashi S, Mori T, Kanamori H, Yabe H, Hama A, Okamoto S, Inamoto Y: High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation. Blood advances. 2019.02; 3 (3): 397-405. ( PubMed , DOI )

  41. Keisuke Tanaka, Shigeo Toyota, Megumi Akiyama, Naoki Wakimoto, Yuichi Nakamura, Yuho Najima, Noriko Doki, Kazuhiko Kakihana, Aiko Igarashi, Takeshi Kobayashi, Kazuteru Ohashi, Daisuke Kudo, Atsushi Shinagawa, Hina Takano, Takayuki Fujio, Yasushi Okoshi, Mitsuo Hori, Takashi Kumagai, Tatsuya Saito, Junichi Mukae, Koh Yamamoto, Ikuyo Tsutsumi, Takuya Komeno, Chikashi Yoshida, Masahide Yamamoto, Hiroshi Kojima, : Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial. Acta Haematol.. 2019.02; 141 (2): 111-118. ( PubMed , DOI )

  42. Konuma T, Shimomura Y, Ozawa Y, Ueda Y, Uchida N, Onizuka M, Akiyama M, Mori T, Nakamae H, Ohno Y, Shiratori S, Onishi Y, Kanda Y, Fukuda T, Atsuta Y, Ishiyama K, Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Induction chemotherapy followed by allogeneic HCT versus upfront allogeneic HCT for advanced myelodysplastic syndrome: A propensity score matched analysis. Hematological oncology. 2019.02; 37 (1): 85-95. ( PubMed , DOI )

  43. Konuma T, Kondo T, Kawata T, Iwato K, Sato Y, Mori T, Ohashi K, Nakazawa H, Sugahara H, Ago H, Eto T, Imamura Y, Fukuda T, Kanda Y, Atsuta Y, Yano S, Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Hematopoietic Cell Transplantation for Acute Panmyelosis with Myelofibrosis: A Retrospective Study in Japan. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019.01; 25 (1): e23-e27. ( PubMed , DOI )

  44. Karigane D, Kikuchi T, Sakurai M, Kato J, Yamane Y, Hashida R, Abe R, Hatano M, Hasegawa N, Wakayama M, Shibuya K, Okamoto S, Mori T: Invasive hepatic mucormycosis: A case report and review of the literature. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2019.01; 25 (1): 50-53. ( PubMed , DOI )

  45. Junichi Tsuchiya, Masahide Yamamoto, Hyeyeol Bae, Takumi Oshima, Tomohiro Yoneyama, Osamu Miura, Ukihide Tateishi: Tumor Identification of Less Aggressive or Indolent Lymphoma With Whole-Body 11C-Acetate PET/CT. Clin Nucl Med. 2019.01; ( PubMed , DOI )

  46. Nomoto H, Takami A, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Morishita E: Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy. International journal of molecular sciences. 2019.01; 20 (1): ( PubMed , DOI )

  47. Makoto Nakagawa, Shuhei Fujita, Takuo Katsumoto, Kazutsune Yamagata, Yoko Ogawara, Ayuna Hattori, Yuki Kagiyama, Daisuke Honma, Kazushi Araki, Tatsuya Inoue, Ayako Kato, Koichiro Inaki, Chisa Wada, Yoshimasa Ono, Masahide Yamamoto, Osamu Miura, Yasuharu Nakashima, Issay Kitabayashi: Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma. Cancer Sci.. 2019.01; 110 (1): 194-208. ( PubMed , DOI )

  48. Akiyama Hiroki, Umezawa Yoshihiro, Ishida Shinya, Okada Keigo, Nogami Ayako, Miura Osamu: Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress CANCER LETTERS. 2019; 453 84-94. ( PubMed , DOI )

  1. Takanobu Morishita, Motohito Okabe, Yuuka Kawaguchi, Yoonha Lee, Marie Ohbiki, Masahide Osaki, Miyo Goto, Hiroaki Araie, Takahiko Sato, Tatsunori Goto, Yukiyasu Ozawa, Koichi Miyamura: Higher Peak Tacrolimus Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation Increase the Risk of Endothelial Cell Damage Complications. Biol Blood Marrow Transplant. 2018.12; 24 (12): 2509-2516. ( PubMed , DOI )

  2. Yamane M, Ogawa Y, Fukui M, Kamoi M, Uchino M, Saijo-Ban Y, Kozuki N, Mukai S, Mori T, Okamoto S, Tsubota K: Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study. Eye & contact lens. 2018.11; 44 Suppl 2 S215-S220. ( PubMed , DOI )

  3. Sakurai M, Watanuki S, Kato J, Hashida R, Yamane Y, Karigane D, Mitsuhashi T, Murata M, Ueno H, Nakazato T, Okamoto S, Mori T: Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission. Internal medicine (Tokyo, Japan). 2018.11; 57 (22): 3299-3302. ( PubMed , DOI )

  4. Fujita Y, Nakazato T, Ito C, Masuda K, Osada Y, Aisa Y, Mori T: A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment. Annals of hematology. 2018.10; 97 (10): 2009-2010. ( PubMed , DOI )

  5. Hong-Nian Liu, Hiroaki Hirata, Yusuke Okuno, Motohito Okabe, Koichi Furukawa: Dopamine and Serotonin Receptors Cooperatively Modulate Pacemaker Activity of Intestinal Cells of Cajal. Chin J Physiol. 2018.10; 61 (5): 302-312. ( PubMed , DOI )

  6. Okamoto S, Teshima T, Kosugi-Kanaya M, Kahata K, Kawashima N, Kato J, Mori T, Ozawa Y, Miyamura K: Extracorporeal photopheresis with TC-V in Japanese patients with steroid-resistant chronic graft-versus-host disease. International journal of hematology. 2018.09; 108 (3): 298-305. ( PubMed , DOI )

  7. 内田 智之, 土岐 典子, 岸田 侑也, 永田 啓人, 山田 裕太, 小西 達矢, 海渡 智史, 黒澤 修兵, 吉藤 康太, 白根 脩一, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 武藤 秀治, 小林 武, 垣花 和彦, 坂巻 壽, 大橋 一輝: Ph+ALLに対する同種造血幹細胞移植後のチロシンキナーゼ阻害剤投与の実際(Clinical impact of TKI therapy after allo-HSCT for Ph+ALL) 臨床血液. 2018.09; 59 (9): 1571. ( ichushi )

  8. 永田 啓人, 名島 悠峰, 岸田 侑也, 小西 達矢, 山田 裕太, 海渡 智史, 黒澤 修兵, 吉藤 康太, 白根 脩一, 内田 智之, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 武藤 秀治, 土岐 典子, 小林 武, 垣花 和彦, 坂巻 壽, 大橋 一輝: 造血幹細胞移植患者における二次癌治療成績の解析(The clinical outcomes of second primary malignancy after allogeneic stem cell transplantation) 臨床血液. 2018.09; 59 (9): 1543. ( ichushi )

  9. 小西 達矢, 土岐 典子, 岸田 侑也, 永田 啓人, 山田 裕太, 海渡 智史, 黒澤 修兵, 吉藤 康太, 白根 脩一, 内田 智之, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 小林 武, 垣花 和彦, 坂巻 壽, 大橋 一輝: 急性骨髄性白血病に対する同種造血幹細胞移植におけるGeriatric nutritional risk indexと予後(Clinical impact of geriatric nutritional risk index of allogeneic-HSCT for AML patients) 臨床血液. 2018.09; 59 (9): 1553. ( ichushi )

  10. 山田 裕太, 武藤 秀治, 岸田 侑也, 小西 達矢, 永田 啓人, 海渡 智史, 黒澤 修兵, 白根 脩一, 吉藤 康太, 稲本 恭子, 内田 智之, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 小林 武, 土岐 典子, 垣花 和彦, 坂巻 壽, 大橋 一輝: 急性骨髄性白血病加療中に多発肝炎症性偽腫瘍を呈した一例(Multiple inflammatory pseudotumors of the liver associated with acute myeloid leukemia) 臨床血液. 2018.09; 59 (9): 1768. ( ichushi )

  11. 海渡 智史, 遠矢 嵩, 中島 祐二朗, 田口 歩, 岸田 侑也, 小西 達矢, 永田 啓人, 山田 裕太, 黒澤 修兵, 吉藤 康太, 白根 脩一, 稲本 恭子, 内田 智之, 五十嵐 愛子, 名島 悠峰, 武藤 秀治, 土岐 典子, 小林 武, 垣花 和彦, 坂巻 壽, 大橋 一輝: 同種造血幹細胞移植後サイトメガロウイルス再活性化の予測(Prediction of CMV reactivation after allogeneic stem cell transplantation using machine learning) 臨床血液. 2018.09; 59 (9): 1633. ( ichushi )

  12. 白根 脩一, 名島 悠峰, 福島 一彰, 関谷 紀貴, 岸田 侑也, 永田 啓人, 山田 裕太, 小西 達矢, 海渡 智史, 黒澤 修兵, 吉藤 康太, 内田 智之, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 武藤 秀治, 小林 武, 土岐 典子, 垣花 和彦, 坂巻 壽, 大橋 一輝: 再発難治急性リンパ性白血病に合併した中枢神経系ムコール症(Cerebral mucormycosis complicated with relapsed-refractory acute lymphoblastic leukemia) 臨床血液. 2018.09; 59 (9): 1688. ( ichushi )

  13. 岸田 侑也, 土岐 典子, 中尾 眞二, 吉岡 康介, 永田 啓人, 山田 裕太, 小西 達矢, 海渡 智史, 黒澤 修兵, 吉藤 康太, 白根 脩一, 内田 智之, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 武藤 秀治, 小林 武, 垣花 和彦, 坂巻 壽, 大橋 一輝: フルダラビン前処置による造血幹細胞移植後、自己造血回復し、AIHAを発症したAA-PNH(AIHA on autologous hematologic recovery after conditioning with fludarabine for allo-HSCT in AA-PNH) 臨床血液. 2018.09; 59 (9): 1815. ( ichushi )

  14. 吉藤 康太, 稲本 恭子, 垣花 和彦, 白石 由紀子, 岸田 侑也, 小西 達矢, 永田 啓人, 山田 裕太, 海渡 智史, 黒澤 修兵, 白根 脩一, 内田 智之, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 土岐 典子, 小林 武, 坂巻 壽, 大橋 一輝: プレバイオティクス摂取が移植関連合併症に与える影響について(Effect of prebiotics on transplant-related complications) 臨床血液. 2018.09; 59 (9): 1544. ( ichushi )

  15. Takanashi S, Nakazato T, Aisa Y, Ito C, Arakaki H, Osada Y, Hirano M, Mori T: The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders. Annals of hematology. 2018.09; 97 (9): 1611-1618. ( PubMed , DOI )

  16. Yoshinaga N, Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Ichinohe T, Atsuta Y, Takaori-Kondo A: Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018.08; 24 (8): 1596-1601. ( PubMed , DOI )

  17. Inamoto Y, Matsuda T, Tabuchi K, Kurosawa S, Nakasone H, Nishimori H, Yamasaki S, Doki N, Iwato K, Mori T, Takahashi S, Yabe H, Kohno A, Nakamae H, Sakura T, Hashimoto H, Sugita J, Ago H, Fukuda T, Ichinohe T, Atsuta Y, Yamashita T, Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group.: Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation. Blood advances. 2018.08; 2 (15): 1901-1913. ( PubMed , DOI )

  18. Nakazato T, Takanashi S, Hirano M, Ito C, Fujita Y, Osada Y, Aisa Y, Mori T: Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma. Annals of hematology. 2018.08; 97 (8): 1489-1491. ( PubMed , DOI )

  19. Kawamura K, Nakasone H, Kurosawa S, Yoshimura K, Misaki Y, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Kusuda M, Kameda K, Wada H, Ishihara Y, Sato M, Terasako-Saito K, Kikuchi M, Kimura SI, Tanihara A, Kako S, Kanamori H, Mori T, Takahashi S, Taniguchi S, Atsuta Y, Kanda Y: Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018.07; 24 (7): 1521-1526. ( PubMed , DOI )

  20. Ishida S, Akiyama H, Umezawa Y, Okada K, Nogami A, Oshikawa G, Nagao T, Miura O: Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2. Oncotarget. 2018.06; 9 (42): 26834-26851. ( PubMed , DOI )

  21. Ogata M, Takano K, Moriuchi Y, Kondo T, Ueki T, Nakano N, Mori T, Uoshima N, Nagafuji K, Yamasaki S, Shibasaki Y, Sakai R, Kato K, Choi I, Jo Y, Eto T, Kako S, Oshima K, Fukuda T: Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018.06; 24 (6): 1264-1273. ( PubMed , DOI )

  22. Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, Hirokawa M, Atsuta Y, Nakaseko C: Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018.06; 24 (6): 1180-1186. ( PubMed , DOI )

  23. Motohashi K, Fujisawa S, Doki N, Kobayashi T, Mori T, Usuki K, Tanaka M, Fujiwara S, Kako S, Aoyama Y, Onoda M, Yano S, Gotoh M, Kanamori H, Takahashi S, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT): Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia. Leukemia & lymphoma. 2018.06; 59 (6): 1332-1337. ( PubMed , DOI )

  24. Successful treatment of breakthrough disseminated Trichosporon asahii fungemia in a patient with acute myeloid leukemia receiving itraconazole prophylaxis. 2018.06; 20 1-3. ( PubMed , DOI )

  25. Yamazaki R, Kikuchi T, Kato J, Sakurai M, Koda Y, Hashida R, Yamane Y, Abe R, Hasegawa N, Okamoto S, Mori T: Recurrent bacterial pneumonia due to immunoglobulin G2 subclass deficiency after allogeneic hematopoietic stem cell transplantation: Efficacy of immunoglobulin replacement. Transplant infectious disease : an official journal of the Transplantation Society. 2018.06; 20 (3): e12863. ( PubMed , DOI )

  26. Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R: Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study. Transfusion medicine reviews. 2018.06; ( PubMed , DOI )

  27. Tokuhira M, Saito S, Okuyama A, Suzuki K, Higashi M, Momose S, Shimizu T, Mori T, Anan-Nemoto T, Amano K, Okamoto S, Takeuchi T, Tamaru JI, Kizaki M: Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression. Leukemia & lymphoma. 2018.05; 59 (5): 1143-1152. ( PubMed , DOI )

  28. Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, Inoue M, Fukuda T, Ichinohe T, Atsuta Y, Kanda Y: Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018.04; 24 (4): 717-725. ( PubMed , DOI )

  29. Yuko Kinowaki, Morito Kurata, Sachiko Ishibashi, Masumi Ikeda, Anna Tatsuzawa, Masahide Yamamoto, Osamu Miura, Masanobu Kitagawa, Kouhei Yamamoto: Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma. Lab. Invest.. 2018.02; 98 (5): 609-619. ( PubMed , DOI )

  30. Okada K, Nogami A, Ishida S, Akiyama H, Chen C, Umezawa Y, Miura O: FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway. Oncotarget. 2018.02; 9 (10): 8870-8886. ( PubMed , DOI )

  31. Sakurai M, Toyama T, Kikuchi T, Kato J, Shimizu T, Koda Y, Karigane D, Yamane Y, Abe R, Yamazaki R, Nakazato T, Nakahara T, Jinzaki M, Okamoto S, Mori T: Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma. International journal of hematology. 2018.02; 107 (2): 194-200. ( PubMed , DOI )

  32. Kohashi S, Toyama T, Hashimoto N, Sakurai M, Kato J, Kikuchi T, Koda Y, Sugita K, Hasegawa N, Yarita K, Kamei K, Okamoto S, Mori T: Sinusitis caused by Exserohilum rostratum after cord blood transplantation for myelodysplastic syndrome: A case report and literature review. Transplant infectious disease : an official journal of the Transplantation Society. 2018.02; 20 (1): ( PubMed , DOI )

  33. Ishigaki S, Masaoka T, Kameyama H, Kawaida M, Kameyama K, Mori T, Kanai T: Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma. Internal medicine (Tokyo, Japan). 2018; 57 (22): 3249-3254. ( PubMed , DOI )

  34. Saito S, Suzuki K, Yoshimoto K, Kaneko Y, Yamaoka K, Shimizu T, Mori T, Okamoto S, Kameyama K, Amano K, Tamaru JI, Tokuhira M, Takeuchi T: Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment. Frontiers in immunology. 2018; 9 621. ( PubMed , DOI )

  35. Muta T, Miyamoto T, Kamimura T, Kanda Y, Nohgawa M, Ueda Y, Iwato K, Sasaki O, Mori T, Uchida N, Iida S, Fukuda T, Atsuta Y, Sunami K: Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan. Acta haematologica. 2018; 139 (1): 35-44. ( PubMed , DOI )

  1. Keigo Okada, Ayako Nogami, Shinya Ishida, Hiroki Akiyama, Cheng Chen, Yoshihiro Umezawa and Osamu Miura: FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway Oncotarget. 2017.12; 9 8870-8886.

  2. Umezawa, Y; Akiyama, H; Okada, K; Ishida, S; Nogami, A; Oshikawa, G; Kurosu, T; Miura, O: Molecular mechanisms for enhancement of stromal cell-derived factor 1-induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1) JOURNAL OF BIOLOGICAL CHEMISTRY. 2017.12; 292 (48): 19639-19655. ( PubMed , DOI )

  3. Yoshihiro Umezawa, Hiroki Akiyama, Keigo Okada, Shinya Ishida, Ayako Nogami, Gaku Oshikawa, Tetsuya Kurosu, Osamu Miura: Molecular mechanisms for enhancement of stromal cell-derived factor 1-induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1). Journal of Biological Chemistry. 2017.12; 292 (48): 19639-19655.

  4. Onishi Y, Mori T, Kako S, Koh H, Uchida N, Kondo T, Kobayashi T, Yabe H, Miyamoto T, Kato K, Suzuki R, Nakao S, Yamazaki H, Adult Aplastic Anemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017.12; 23 (12): 2137-2142. ( PubMed , DOI )

  5. Kurosawa S, Oshima K, Yamaguchi T, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y: Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017.10; 23 (10): 1749-1758. ( PubMed , DOI )

  6. Masahide Yamamoto, Sayaka Suzuki, Jun-Ichi Mukae, Keisuke Tanaka, Ken Watanabe, Gaku Oshikawa, Tetsuya Fukuda, Naomi Murakami, Osamu Miura: Atypical chronic myeloid leukemia with isochromosome (X)(p10): A case report. Oncol Lett. 2017.09; 14 (3): 3717-3721. ( PubMed , DOI )

  7. He J, Ogawa Y, Mukai S, Saijo-Ban Y, Kamoi M, Uchino M, Yamane M, Ozawa N, Fukui M, Mori T, Okamoto S, Tsubota K: In Vivo Confocal Microscopy Evaluation of Ocular Surface with Graft-Versus-Host Disease-Related Dry Eye Disease. Scientific reports. 2017.09; 7 (1): 10720. ( PubMed , DOI )

  8. Saburi M, Kohashi S, Kato J, Koda Y, Sakurai M, Toyama T, Kikuchi T, Karigane D, Yuda S, Yamane Y, Hashida R, Abe R, Nakazato T, Hirahashi J, Ogata M, Okamoto S, Mori T: Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation. International journal of hematology. 2017.09; 106 (3): 431-435. ( PubMed , DOI )

  9. Murakami K, Kohashi S, Sakurai M, Kato J, Toyama T, Koda Y, Yamane Y, Hashida R, Abe R, Yamazaki R, Kikuchi T, Shimizu T, Suzuki S, Hasegawa N, Okamoto S, Mori T: Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis. International journal of hematology. 2017.09; 106 (3): 436-440. ( PubMed , DOI )

  10. Andreas Herrmann, Christoph Lahtz, Toshikage Nagao, Joo Y Song, Wing C Chan, Heehyoung Lee, Chanyu Yue, Thomas Look, Ronja Mülfarth, Wenzhao Li, Kurt Jenkins, John Williams, Lihua E Budde, Stephen Forman, Larry Kwak, Thomas Blankenstein, Hua Yu: CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity. Cancer Res.. 2017.09; 77 (18): 5118-5128. ( PubMed , DOI )

  11. M Matsushita, K Ozawa, T Suzuki, M Nakamura, N Nakano, S Kanchi, D Ichikawa, E Matsuki, M Sakurai, D Karigane, H Kasahara, N Tsukamoto, T Shimizu, T Mori, H Nakajima, S Okamoto, Y Kawakami, Y Hattori: CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients. Blood Cancer Journal. 2017.09; 7 (9): e601. ( PubMed , DOI )

  12. Kondo T, Nagamura-Inoue T, Tojo A, Nagamura F, Uchida N, Nakamae H, Fukuda T, Mori T, Yano S, Kurokawa M, Ueno H, Kanamori H, Hashimoto H, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Ohashi K: Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia. American journal of hematology. 2017.09; 92 (9): 902-908. ( PubMed , DOI )

  13. Namkoong H, Ishii M, Mori T, Sugiura H, Tasaka S, Sakurai M, Koda Y, Kato J, Hasegawa N, Okamoto S, Betsuyaku T: Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation. BMC pulmonary medicine. 2017.09; 17 (1): 123. ( PubMed , DOI )

  14. Tanaka K, Oshikawa G, Akiyama H, Ishida S, Nagao T, Yamamoto M, Miura O: Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report. Oncology letters. 2017.07; 14 (1): 97-102. ( PubMed , DOI )

  15. Arakaki H, Nakazato T, Osada Y, Ito C, Aisa Y, Mori T: Comparison of R-CVP with R-CHOP for very elderly patients aged 80 or over with diffuse large B cell lymphoma. Annals of hematology. 2017.07; 96 (7): 1225-1226. ( PubMed , DOI )

  16. Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Kawakita T, Mori T, Hoshino T, Onizuka M, Ozawa Y, Yoshida S, Ueda Y, Mizuno I, Atsuta Y, Mizuta S, Japan Society for Haematopoietic Cell Transplantation.: Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults. British journal of haematology. 2017.07; 178 (1): 106-111. ( PubMed , DOI )

  17. Daiki Karigane, Keiyo Takubo: Metabolic regulation of hematopoietic and leukemic stem/progenitor cells under homeostatic and stress conditions. International Journal of Hematology. 2017.07; 106 (1): 18-26. ( PubMed , DOI )

  18. Kikuchi T, Mori T, Shimizu T, Koda Y, Abe R, Kurihara Y, Funakoshi T, Yamagami J, Sato H, Tsunoda K, Amagai M, Okamoto S: Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus. Annals of hematology. 2017.07; 96 (7): 1221-1222. ( PubMed , DOI )

  19. Uchino K, Mizuno S, Sato-Otsubo A, Nannya Y, Mizutani M, Horio T, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Ogawa S, Takami A: Toll-like receptor genetic variations in bone marrow transplantation. Oncotarget. 2017.07; 8 (28): 45670-45686. ( PubMed , DOI )

  20. Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, Reina Watanabe, Yutaka Shimazu, Yasufumi Masaki, Saburo Tsunoda, Chizuko Hashimoto, Kayoko Murayama, Takahiro Yano, Rumiko Okamoto, Ako Kikuchi, Kazuo Tamura, Kazuya Sato, Kazutaka Sunami, Hirohiko Shibayama, Rishu Takimoto, Rika Ohshima, Hiromichi Takahashi, Yukiyoshi Moriuchi, Tomohiro Kinoshita, Masahide Yamamoto, Ayumi Numata, Hideaki Nakajima, Ikuo Miura, Kengo Takeuchi: The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis. Leuk. Lymphoma. 2017.06; 1-8. ( PubMed , DOI )

  21. Horio T, Mizuno S, Uchino K, Mizutani M, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Takami A: The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation. Transplant immunology. 2017.06; 42 34-39. ( PubMed , DOI )

  22. Masahide Yamamoto, Ken Watanabe, Tetsuya Fukuda, Osamu Miura: Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study. Anticancer Res.. 2017.05; 37 (5): 2655-2662. ( PubMed , DOI )

  23. Yanada M, Yano S, Kanamori H, Gotoh M, Emi N, Watakabe K, Kurokawa M, Nishikawa A, Mori T, Tomita N, Murata M, Hashimoto H, Henzan H, Kanda Y, Sawa M, Kohno A, Atsuta Y, Ichinohe T, Takami A: Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide. Leukemia & lymphoma. 2017.05; 58 (5): 1061-1067. ( PubMed , DOI )

  24. Hashimoto N, Mori T, Hashida R, Sakurai M, Koda Y, Toyama T, Kato J, Okamoto S: False-positive serum (1, 3)-β-D-glucan elevation due to intake of seaweed in a hematopoietic stem cell transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society. 2017.04; 19 (2): ( PubMed , DOI )

  25. Kobayashi R, Mitsui T, Fujita N, Osumi T, Aoki T, Aoki K, Suzuki R, Fukuda T, Miyamoto T, Kato K, Nakamae H, Goto H, Eto T, Inoue M, Mori T, Terui K, Onizuka M, Koh K, Koga Y, Ichinohe T, Sawada A, Atsuta Y, Suzumiya J: Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation. International journal of hematology. 2017.03; 105 (3): 369-376. ( PubMed , DOI )

  26. Mori T, Kanda Y, Takenaka K, Okamoto S, Kato J, Kanda J, Yoshimoto G, Gondo H, Doi S, Inaba M, Kodera Y: Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial. International journal of hematology. 2017.02; 105 (2): 206-212. ( PubMed , DOI )

  27. Konuma T, Miyazaki Y, Uchida N, Ohashi K, Kondo T, Nakamae H, Takahashi S, Mori T, Ozawa Y, Kato C, Iwato K, Fukuda T, Ichinohe T, Atsuta Y, Ishiyama K, Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017.01; 23 (1): 75-80. ( PubMed , DOI )

  28. Takenaka K, Shimoda K, Uchida N, Shimomura T, Nagafuji K, Kondo T, Shibayama H, Mori T, Usuki K, Azuma T, Tsutsumi Y, Tanaka J, Dairaku H, Matsuo K, Ozawa K, Kurokawa M, Arai S, Akashi K: Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. International journal of hematology. 2017.01; 105 (1): 59-69. ( PubMed , DOI )

  29. Sasaki T, Akiyama M, Kaneko Y, Mori T, Yasuoka H, Suzuki K, Yamaoka K, Okamoto S, Takeuchi T: Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease. RMD open. 2017; 3 (1): e000432. ( PubMed , DOI )

  1. Koichi Miyamura, Toshihiro Miyamoto, Mitsune Tanimoto, Kazuhito Yamamoto, Shinya Kimura, Tatsuya Kawaguchi, Itaru Matsumura, Tomoko Hata, Hisashi Tsurumi, Shigeki Saito, Masayuki Hino, Seiji Tadokoro, Kuniaki Meguro, Hideo Hyodo, Masahide Yamamoto, Kohmei Kubo, Junichi Tsukada, Midori Kondo, Makoto Aoki, Hikaru Okada, Masamitsu Yanada, Kazuma Ohyashiki, Masafumi Taniwaki: Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy. Leuk. Res.. 2016.12; 51 11-18. ( PubMed , DOI )

  2. Hiroki Akiyama, Hiroshi Takase, Fumito Kubo, Tohru Miki, Masahide Yamamoto, Makoto Tomita, Manabu Mochizuki, Osamu Miura, Ayako Arai: High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma. Cancer Science. 2016.10; 107 (10): 1458-1464. ( PubMed , DOI )

  3. Karigane D, Kobayashi H, Morikawa T, Ootomo Y, Sakai M, Nagamatsu G, Kubota Y, Goda N, Matsumoto M, Nishimura EK, Soga T, Otsu K, Suematsu M, Okamoto S, Suda T, Takubo K: p38α Activates Purine Metabolism to Initiate Hematopoietic Stem/Progenitor Cell Cycling in Response to Stress. Cell stem cell. 2016.08; 19 (2): 192-204. ( PubMed , DOI )

  4. Masahide Yamamoto, Kazuteru Ohashi, Kazuhiko Kakihana, Yuichi Nakamura, Takuya Komeno, Hiroshi Kojima, Satoshi Morita, Hisashi Sakamaki: A multicenter clinical study to determine the feasible initial dose of lenalidomide for maintenance therapy in patients with multiple myeloma following autologous peripheral blood stem-cell transplantation. Mol Clin Oncol. 2016.06; 4 (6): 965-970. ( PubMed , DOI )

  5. Yoshihiro Umezawa, Tetsuya Kurosu, Hiroki Akiyama, Nang Wu, Ayako Nogami, Toshikage Nagao, Osamu Miusa: Down regulation of Chk1 by p53 plays a role in synergistic induction of apoptosis by chemotherapeutics and inhibitors for Jak2 or BCR/ABL in hematopoietic cells. Oncotarget. 2016.06; ( PubMed )

  6. Shunichiro Yasuda, Masahide Yamamoto, Tetsuya Fukuda, Yasufumi Ohtsuka, Osamu Miura: Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with Eculizumab. Intern. Med.. 2016.05; 55 (9): 1171-1175. ( PubMed , DOI )

  7. Arai A, Sakashita C, Hirose C, Imadome K, Yamamoto M, Jinta M, Fujiwara S, Tomita M, Shimizu N, Morio T, and Miura O.: Hematopoietic stem cell transplantation for adults with EBV-positive T- or NK-cell lymphoproliferative disorders: efficacy and predictive markers Bone Marrow Transplantation. 2016.02; ( DOI )

  8. Wakaba Yamaguchi, Naofumi Yui, Toshikage Nagao, Gaku Oshikawa, Mariko Negi, Soichiro Iimori, Tomokazu Okado, Tatemitsu Rai, Shinichi Uchida: Bence-Jones Protein λ-type Multiple Myeloma Patient Withdrawn from Maintenance Hemodialysis after Long-term Bortezomib and Dexamethasone Therapy. Internal Medicine. 2016; 55 (3): 263-268. ( PubMed , DOI )

  1. Motohito Okabe, Sachiko Ito, Naomi Nishio, Yuriko Tanaka, Ken-Ichi Isobe: Thymic Epithelial Cells Induced from Pluripotent Stem Cells by a Three-Dimensional Spheroid Culture System Regenerates Functional T Cells in Nude Mice. Cell Reprogram. 2015.10; 17 (5): 368-375. ( PubMed , DOI )

  2. Emi Uchida, Ken Watanabe, Reina Arai, Masahide Yamamoto, Masayoshi Souri, Tsukasa Osaki, Akitada Ichinose, Osamu Miura, Takatoshi Koyama: Autoimmune Hemorrhaphilia Resulting from Autoantiboy against the A Subunit of Factor XIII. Internal Medicine. 2015.09; 54 (18): 2383-2387.

  3. T Nagao, G Oshikawa, S Ishida, H Akiyama, Y Umezawa, A Nogami, T Kurosu, O Miura: A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival. Blood Cancer J. 2015.05; 5 e314. ( PubMed , DOI )

  4. Hiroshi Kobayashi, Chiharu I Kobayashi, Ayako Nakamura-Ishizu, Daiki Karigane, Hiroshi Haeno, Kimiyo N Yamamoto, Taku Sato, Toshiaki Ohteki, Yoshihiro Hayakawa, Glen N Barber, Mineo Kurokawa, Toshio Suda, Keiyo Takubo: Bacterial c-di-GMP affects hematopoietic stem/progenitors and their niches through STING. Cell Rep. 2015.04; 11 (1): 71-84. ( PubMed , DOI )

  5. Nogami Ayako, Oshikawa Gaku, Okada Keigo, Fukutake Shusaku, Umezawa Yoshihiro, Nagao Toshikage, Kurosu Tetsuya, Miura Osamu: FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia. Oncotarget. 2015.04; 6 (11): 9189-9205. ( PubMed )

  6. Masahide Yamamoto, Keigo Okada, Hiroki Akiyama, Tetsuya Kurosu, Osamu Miura: Evaluation of the efficacy of maintenance therapy for low-to-intermediate-risk acute promyelocytic leukemia in molecular remission: A retrospective single-institution study. Mol Clin Oncol. 2015.03; 3 (2): 449-453. ( PubMed , DOI )

  7. Hiroki Akiyama, Masahide Yamamoto, Chizuko Sakashita, Yoshihiro Umezawa, Tetsuya Kurosu, Naomi Murakami, Osamu Miura: Therapy-related Leukemia with Inv(16)(p13.1q22) and Type D CBFB/MYH11 Developing after Exposure to Irinotecan-containing Chemoradiotherapy. Intern. Med.. 2015; 54 (6): 651-655. ( PubMed , DOI )

  1. Chen-Yi Lai, Satoshi Yamazaki, Motohito Okabe, Sachie Suzuki, Yoshihiro Maeyama, Yasuaki Iimura, Masafumi Onodera, Shigeru Kakuta, Yoichiro Iwakura, Masanori Nojima, Makoto Otsu, Hiromitsu Nakauchi: Stage-specific roles for CXCR4 signaling in murine hematopoietic stem/progenitor cells in the process of bone marrow repopulation. Stem Cells. 2014.07; 32 (7): 1929-1942. ( PubMed , DOI )

  2. Karigane D, Takaya S, Seki Y, Mastumoto Y, Onose A, Kosakai A, Sugaya N, Mori T: Cytomegalovirus enteritis in immunocompetent subjects: a case report and review of the literature. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2014.05; 20 (5): 325-9. ( PubMed , DOI )

  3. Koji Eshima, Motohito Okabe, Satoshi Kajiura, Haruka Noma, Nobukata Shinohara, Kazuya Iwabuchi: Significant involvement of nuclear factor-κB-inducing kinase in proper differentiation of αβ and γδ T cells. Immunology. 2014.02; 141 (2): 222-232. ( PubMed , DOI )

  4. Nagao T, Kurosu T, Umezawa Y, Nogami A, Oshikawa G, Tohda S, Yamamoto M, Miura O: Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera. PLoS ONE. 2014; 9 (1): e84746. ( PubMed , DOI )

  1. Nao Suzuki, Satoshi Yamazaki, Tomoyuki Yamaguchi, Motohito Okabe, Hideki Masaki, Satoshi Takaki, Makoto Otsu, Hiromitsu Nakauchi: Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol Ther. 2013.07; 21 (7): 1424-1431. ( PubMed , DOI )

  2. Nan Wu, Tetsuya Kurosu, Gaku Oshikawa, Toshikage Nagao, Osamu Miura: PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells. Int. J. Oncol.. 2013.02; 42 (2): 419-428. ( PubMed , DOI )

  3. Tetsuya Kurosu, Toshikage Nagao, Nan Wu, Gaku Oshikawa, Osamu Miura: Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosis. PLoS ONE. 2013; 8 (11): e79478. ( PubMed , DOI )

  1. Naoto Takahashi, Taiichi Kyo, Yasuhiro Maeda, Takashi Sugihara, Kensuke Usuki, Tatsuya Kawaguchi, Noriko Usui, Shinichiro Okamoto, Yokiko Ohe, Shigeki Ohtake, Kunio Kitamura, Masahide Yamamoto, Hirofumi Teshima, Toshiko Motoji, Toshiharu Tamaki, Kenichi Sawada, Kazuma Ohyashiki: Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia. Haematologica. 2012.06; 97 (6): 903-906. ( PubMed , DOI )

  2. Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, Reina Watanabe, Yutaka Shimazu, Yasufumi Masaki, Saburo Tsunoda, Chizuko Hashimoto, Kayoko Murayama, Takahiro Yano, Rumiko Okamoto, Ako Kikuchi, Kazuo Tamura, Kazuya Sato, Kazutaka Sunami, Hirohiko Shibayama, Rishu Takimoto, Rika Ohshima, Yoshihiro Hatta, Yukiyoshi Moriuchi, Tomohiro Kinoshita, Masahide Yamamoto, Ayumi Numata, Yoshiaki Ishigatsubo, Kengo Takeuchi: Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era. Cancer Sci.. 2012.02; 103 (2): 245-251. ( PubMed , DOI )

  3. Masahide Yamamoto, Kazuteru Ohashi, Yuka Hirashima, Takeshi Kobayashi, Kazuhiko Kakihana, Hideki Akiyama, Hisashi Sakamaki: Poor outcome of myeloablative conditioned allogeneic bone marrow transplantation for myelofibrosis. Intern. Med.. 2012; 51 (10): 1183-1186. ( PubMed )

  4. Tomoyuki Yamaguchi, Sanae Hamanaka, Akihide Kamiya, Motohito Okabe, Mami Kawarai, Yukiko Wakiyama, Ayumi Umino, Tomonari Hayama, Hideyuki Sato, Youn-Su Lee, Megumi Kato-Itoh, Hideki Masaki, Toshihiro Kobayashi, Satoshi Yamazaki, Hiromitsu Nakauchi: Development of an all-in-one inducible lentiviral vector for gene specific analysis of reprogramming. PLoS One. 2012; 7 (7): e41007. ( PubMed , DOI )

  1. Gaku Oshikawa, Toshikage Nagao, Nan Wu, Tetsuya Kurosu, Osamu Miura: c-Cbl and Cbl-b ligases mediate 17-allylaminodemethoxygeldanamycin-induced degradation of autophosphorylated Flt3 kinase with internal tandem duplication through the ubiquitin proteasome pathway. J. Biol. Chem.. 2011.09; 286 (35): 30263-30273. ( PubMed , DOI )

  2. Toshikage Nagao, Gaku Oshikawa, Nan Wu, Tetsuya Kurosu, Osamu Miura: DNA damage stress and inhibition of Jak2-V617F cause its degradation and synergistically induce apoptosis through activation of GSK3β. PLoS ONE. 2011; 6 (11): e27397. ( PubMed , DOI )

  1. Motohito Okabe, Makoto Otsu, Dong Hyuck Ahn, Toshihiro Kobayashi, Yohei Morita, Yukiko Wakiyama, Masafumi Onodera, Koji Eto, Hideo Ema, Hiromitsu Nakauchi: Definitive proof for direct reprogramming of hematopoietic cells to pluripotency. Blood. 2009.08; 114 (9): 1764-1767. ( PubMed , DOI )

  2. Yamamoto M, Kakihana K, Ohashi K, Yamaguchi T, Tadokoro K, Akiyama H, Sakamaki H: Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR. Int J Hematol. 2009.05; 89 (4): 482-488. ( PubMed , DOI )

  1. Tetsuya Kurosu, Kana Tsuji, Manabu Ohki, Tohru Miki, Masahide Yamamoto, Kazuhiko Kakihana, Takatoshi Koyama, Shuichi Taniguchi, Osamu Miura: A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25). Int. J. Hematol.. 2008.09; 88 (2): 192-196. ( PubMed , DOI )

  1. Atsuhiko Oikawa, Koichi Ito, Hirotoshi Seguchi, Motohito Okabe, Fujio Migishima, Koji Eshima, Sadahiro Azuma, Si-Young Song, Takehisa Kaneko, Nobukata Shinohara: Development of immunocompetent lymphocytes in vivo from murine umbilical cord blood cells. Transplantation. 2007.07; 84 (1): 23-30. ( PubMed , DOI )

  1. Motohito Okabe, Masato Enomoto, Haruki Maeda, Kazuyuki Kuroki, Kenzo Ohtsuki: Biochemical characterization of suramin as a selective inhibitor for the PKA-mediated phosphorylation of HBV core protein in vitro. Biol Pharm Bull. 2006.09; 29 (9): 1810-1814. ( PubMed , DOI )

  2. Takatoshi Koyama, Toshikage Nagao, Hidefumi Tsunozaki, Morio Arai, Osamu Miura: Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII. Pathophysiol. Haemost. Thromb.. 2006; 35 (5): 405-407. ( PubMed , DOI )

  1. Kazuhiko Kakihana, Masahide Yamamoto, Mitsuko Iiyama, Osamu Miura: Calmodulin physically interacts with the erythropoietin receptor and enhances Jak2-mediated signaling. Biochem. Biophys. Res. Commun.. 2005.09; 335 (2): 424-431. ( PubMed , DOI )

  2. Yamamoto M, Kakihana K, Kurosu T, Murakami N, Miura O: Clonal evolution with inv(11)(p15q22) and NUP98/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia. Cancer Genet Cytogenet. 2005.03; 157 (2): 104-108. ( PubMed , DOI )

  1. Yamamoto M, Kurosu T, Kakihana K, Mizuchi D, Miura O: The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinase. Biochem Biophys Res Commun. 2004.07; 319 (4): 1272-1275. ( PubMed , DOI )

  1. Asuka Kono, Keisuke Tanaka , Tomohito Shimada , Kana Bando, Atsushi Takahata, Satoshi Koi, Masahide Yamamoto, Takehiko Mori, Shigeo Toyota : Allogeneic stem cell transplantation for refractory ALK-positive anaplastic large cell lymphoma after achieving complete response by alectinib 2024.03; 65 (3): 158-63.

  1. Tomoyasu Jo, Tomoko Henzan, Daisuke Tomizawa, Satoru Yoshihara, Kaoru Kahata, Minami Yamada-Fujiwara, Yoshiki Okuyama, Norio Shiba, Keiko Fujii, Yoshihiro Umezawa, Rie Yamazaki, Wataru Takeda, Ryo Hanajiri, Kentaro Fukushima, Naoya Mimura, Junko Ikemoto, Keita Iwaki, Noboru Yonetani, Shin-Ichiro Fujiwara, Masaki Ri, Tokiko Nagamura-Inoue, Ryuji Tanosaki, Yasuyuki Arai: Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy. Rinsho Ketsueki. 2023; 64 (5): 331-337. ( PubMed , DOI )

  2. Hirate T, Kitazawa H, Sakaguchi H, Akita N, Hasegawa C, Yamamoto K, Kutsuna S, Mikita K, Mori T, Hama A, Yoshida N: Cerebral toxoplasmosis developed after unrelated bone marrow transplantation for acute myeloid leukemia. Rinsho ketsueki. 2023; 64 (10): 1275-1279. ( PubMed , DOI )

  3. Koi S, Nogami A, Fujiwara H, Bando K, Saito M, Osada Y, Tanaka K, Sakashita C, Yoshifuji K, Okada K, Umezawa Y, Nagao T, Yamamoto M, Mori T: Acute promyelocytic leukemia with asymptomatic cerebral hemorrhage. Rinsho ketsueki. 2023; 64 (11): 1426-1430. ( PubMed , DOI )

  1. Kimura M, Nishiyama Y, Ueda H, Kitajo A, Arimatsu T, Kuboki M, Takahata A, Saito M, Sakashita C, Okada K, Umezawa Y, Nagao T, Yamamoto M, Tohda S, Tanabe M, Mori T, Nogami A: Perioperative management of laparoscopic cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab treatment 2022; 63 (4): 260-264. ( PubMed , DOI )

  1. Nogami A, Yamamoto M, Yamamoto K, Ito M, Umezawa Y, Tohda S, Miura O, Fukuda T: Marginal zone lymphoma-like primary bone marrow lymphoma with long-term pancytopenia preceding diagnosis Rinsho ketsueki. 2020.10; 61 (10): 1469-1475. ( PubMed , DOI )

  2. Satoshi Koi, Kosuke Arai, Ayako Nogami, Hayato Toma, Masahide Yamamoto, Osamu Miura, Toshikage Nagao: Impaired hematopoiesis due to copper deficiency in a hemodialysis patient supplemented with zinc. Rinsho Ketsueki. 2020.10; 61 (10): 1487-1491. ( PubMed , DOI )

  3. Kota Yoshifuji, Keisuke Kataoka: Genetic alterations and lymphoma 2020.05; 61 (5): 503-509. ( ichushi )

  1. Umezawa Y, Kawamata N: Novel therapies for acute myeloid leukemia based on genomic aberrations The Japanese journal of clinical hematology. 2019; 60 (6): 594-599. ( PubMed , DOI )

  1. Tomoko Ymamashita, Yoshihiro Umezawa, Ken Watanabe, Tetsuya Fukuda, Norihiko Kawamata, Osamu Miura, Masahide Yamamoto: Busulfan-based conditioning regimen for autologous stem-cell transplantation in patients with central nervous system lymphoma Journal of Hematopoietic Cell Transplantation. 2018.10; 7 (4): 145-151. ( DOI )

  1. Megumi Akiyama, Kota Yoshifuji, Tetsuya Fukuda, Shuji Tohda, Tohru Miki, Osamu Miura, Masahide Yamamoto: Fulminant visceral disseminated varicella-zoster virus infection without skin involvement in a patient with autoimmune hemolytic anemia on prednisolone therapy. Rinsho Ketsueki. 2016.04; 57 (4): 467-471. ( PubMed , DOI )

  2. Uchida Emi, Watanabe Ken, Oshikawa Gaku, Sakasita Chizuko, Kurosu Tetsuya, Fukuda Tetsuya, Arai Ayako, Murakami Naoki, Miura Osamu, Yamamoto Masahide: Refractory primary myeloid sarcoma of the breast with MLL-AF9 rearrangement. The Japanese Journal of Clinical Hematology. 2016.01; 57 (1):

  1. Toshikage Nagao, Osamu Miura: Analyses of Proliferation and Survival Signaling from both Jak2-V617F and Lyn Involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 Cell Line Newly Established from Acute Myeloid Leukemia Transformed from Polycythemia Vera BioMedCircus. 2014.02;

  1. Satoshi Nishiwaki, Isamu Sugiura, Takahiko Sato, Miki Kobayashi, Masahide Osaki, Masashi Sawa, Yoshitaka Adachi, Motohito Okabe, Shigeki Saito, Takanobu Morishita, Akio Kohno, Takahiro Nishiyama, Hiroatsu Iida, Shingo Kurahashi, Yachiyo Kuwatsuka, Daisuke Sugiyama, Sachiko Ito, Hiroyoshi Nishikawa, Hitoshi Kiyoi: Autologous peripheral blood stem cell transplantation for Philadelphia chromosome‐positive acute lymphoblastic leukemia is safe but poses challenges for long‐term maintenance of molecular remission: Results of the Auto‐Ph17 study eJHaem. 2023.03; 4 (2): 358-369. ( PubMed , DOI )

To the head of this page.▲